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ABSTRACT 
Background: HIV and AIDS is one of the major public health problems facing South Africa 
today. In 2005, it was estimated that 5.54 million people were living with HIV in South 
Africa, which means that 18.8% of the population between the ages of 15 – 49 years are 
infected with HIV. This makes South Africa the developing country worst affected by the 
HIV pandemic. The severity of the HIV epidemic is closely linked to poverty and other 
socio-economic factors. The National Department of Health of South Africa launched the 
National Operational Plan for Comprehensive HIV and AIDS management, treatment, care, 
and support in 2007 to ensure that ART is freely available in the public health sector.  It is 
estimated that by mid-2008 approximately 568, 000 HIV infected patients were receiving 
ART at South African hospitals.  
Suboptimal adherence to ART is pervasive despite specific protocols to prepare patients for 
long-term adherence prior to treatment initiation. Known barriers to ART adherence have 
been categorized as patient, socio-economic, service, therapy/regimen and community-
related factors. Effective delivery of ART services requires an understanding of patients’ 
knowledge, attitudes, and beliefs about ART and how these influence their adherence.  
 
Aim: The aim of the study was to assess adherence to antiretroviral therapy and knowledge, 
attitudes and beliefs about ART among people on ART at Shongwe hospital in Nkomazi 
region in Mpumalanga province, South Africa.  
 
Methodology: A descriptive, cross-sectional survey was conducted among 184 patients 
receiving ART at Shongwe hospital in Mpumalanga. Data was collected through self-
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administration and face-to-face interviews. Quantitative data was analysed using the SPSS 
version 16.0 and for stratification Epi-Info version 3.4.1 was used.  
Results: All participants were on first line regimens: lamivudine/stavudine/stocrine or 
efivarenz (65.6%); and lamivudine/stavudine/nevirapine (34%). Self-reported adherence was 
high - 92.4% and 84.2% of participants reported optimal adherence over the previous two 
days and seven days, respectively. Disclosure of HIV status and being on ART was high 
among the respondents (97% and 97.3%) respectively. The most common barriers to missing 
doses were problems travelling to the clinic (22.3%), forgetting (19.6%), and sleeping away 
from home (18.5%). There was significant association between participants knowing that 
“missing doses of ART leads to disease progression”, and ART adherence on two day recall 
(p=0.00) and seven day recall (p=0.02). There was a significant association between 
disclosure of HIV status and ART adherence on two day recall (p=0.01). Significantly more 
participants who disclosed being on ART (98.2%) reported optimal adherence over the 
previous two days (p = 0.00) and seven days (p = 0.00) compared to those who did not 
disclose being on ART.  Participants who reported forgetfulness were 76% less likely (95% 
CI: 0.09-0.65) and 92% less likely (95% CI: 0.04 – 0.17) to have optimal adherence over 
two and seven days, respectively, than participants who did not report forgetfulness to be a 
barrier. 
 
Conclusion: Adherence levels in Nkomazi region are to be comparable with those in other 
regions in South Africa, despite the fact that participants were facing financial constraints 
and high unemployment rates. These study findings emphasize the need for strengthening 
communication between patients and health care providers, and the need for overcoming 
access barriers related to the services, forgetfulness and sleeping away from home. 
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 CHAPTER ONE 
INTRODUCTION 
1.1 Background  
HIV and AIDS is one of the major public health problems facing South Africa today (Hosegood 
et al., 2007; Department of Health, 2007; Woods, Cope and Eley, 2008). The Joint United 
Nations Programme on HIV/AIDS and World Health Organisation (WHO) estimated the number 
of people living with HIV and AIDS (PLWHA) at the end of 2006 to be 39.5 million worldwide 
(UNAIDS, 2004; WHO, 2005). Approximately 10% of the world's population live in sub-
Saharan Africa, 64% of all people living with HIV live in this region. According to UNAIDS 
(2005), about 3.28 million pregnant women who were HIV infected gave birth and 75% of this 
group of women reside in sub-Saharan Africa. This situation leads to 700 000 new HIV 
infections in children in this region.   
1.1.1 Human Immunodeficiency Virus (HIV) 
This is a virus that directly attacks human immune system and cripples the physiological 
defences designed to fight and protect people from diseases (Metzler, 2007). HIV slowly 
diminishes the total number of CD4 cell count in the human body and makes the body 
ineffective to diseases (Van Dyk, 2001). HIV infection is linked with a clinically stable 
asymptomatic stage that can last for several years.  
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1.1.2 Acquired Immune Deficiency Syndrome (AIDS) 
This means that a person gets infected with HI virus, and then the virus weakens the body’s 
immune system that fights diseases. When a person is HIV infected possibilities of experiencing 
health problems are very high. According to Van Dyk (2001), AIDS is the combination of many 
different diseases that manifest in the body after HIV has weakened the body’s immune system 
to such an extent that it can no longer fight diseases. AIDS is caused by HIV, which can be 
spread through sperm, blood, breast milk and vaginal secretions. The most common route of 
transmission is unprotected sex. However, among particular risk groups, other methods of 
transmission may be dominant. For instance, among intravenous drug users the use of 
contaminated needles is a major cause of transmission. HIV spreads rapidly in situations where 
conflict, disasters, or socioeconomic pressures contribute to the displacement of people and 
disruption of family life. In these situations, women and children are especially vulnerable 
(WHO, 2006). 
 
1.2 HIV and AIDS in South Africa 
According to World Health Organisation (2005), South Africa’s prevalence rate of HIV is 
estimated at 16.2%.  According to the Department of Health (2007), about 5.54 million people 
were estimated to be living with HIV in South Africa in 2005; that means that 18.8% of the 
populations between the ages of 15 – 49 years are infected with HIV. This makes South Africa 
one of the developing countries worst affected by the HIV epidemic. The severity of the HIV 
pandemic is closely linked to poverty and other socio-economic factors (Booysen, 2004; Mills et 
al., 2006; Department of Health, 2007). In addition, a study conducted in South Africa indicated 
that 49% of people are dependent on social grants for survival (Louwagie, Bachmann, Meyer, 
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Booysen, Fairall and Heunis, 2007). Department of Health (2007) and Bradshaw and Nannan 
(2006) point out that HIV/AIDS is the leading cause of death among South Africans: 1.8 million 
AIDS related deaths had occurred in South Africa since the beginning of the HIV epidemic. The 
Department of Health (2007) reports that around 740 000 deaths in South Africa occurred in 
2006, of which 350 000 deaths were due to AIDS related diseases. In addition, the Department of 
Health (2007) reports that 71% of all the deaths were within the 15 – 49 age groups in the 
country and were due to AIDS related diseases. This shows that HIV and AIDS negatively 
affected adolescents, early and middle adulthood. South Africa is experiencing the devastating 
effects of the AIDS epidemic on families and communities, children, grandparents, economy and 
health and more than a million children were orphaned because of the disease in 2006 (Van Wyk 
et al., 2006; Shaikh, 2007; Hosegood et al., 2007). The number of orphans and vulnerable 
children is increasing because their parents died of AIDS related diseases. In 2004, it was 
projected that there were 2.2 million orphaned children;  meaning 13% of all children under 18 
had lost either mother or father due to AIDS-related diseases (UNICEF/UNAIDS, 2004). In 
South Africa 300 000 children under the age of 18 years experienced the death of their parents 
(Department of Health, 2007). The Department of Health and Actuarial Society of South Africa 
(2006) also reports that 1.5 million children under the age of 18 were maternal or double orphans 
(that is had lost a mother or both parents), and 66% of these children had been orphaned as a 
result of HIV and AIDS. UNAIDS (2006) reports that people in productive age are hardest hit by 
HIV; leading to the destabilizing of the local economy and many children being orphaned. 
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1.3 Highly Active Antiretroviral Therapy  
Highly Active Antiretroviral Therapy (HAART) is a triple therapy used to prevent HIV from 
developing resistance to ART drugs, also uses three or more antiretroviral medication from at 
least two of the classes and is the recommended form of treatment (WHO, 2006; Metzler, 2007; 
National Department of Health, 2007; Duse et al., 2008). The purpose of these three drugs is to 
stop the progression of the HI virus, to reduce the HIV viral load in the blood, and improve the 
CD4 cell count of the patient to remain at a baseline count between 500 and 2010 cells/mm³. 
ART drugs are divided into different classes according to where they act in the life cycle of HIV. 
These drugs are not a cure, if taken correctly, as instructed they make patients healthy and extend 
their lives. At the moment there are three classes of drugs available in South Africa. The first 
class is the Nucleosidal Reverse Transcriptase Inhibitors (NRTIs) which is used to block the 
enzyme reverse transcriptase indirectly. The second class is made up of Non-Nucleoside Reverse 
Transcriptase Inhibitors (NNRTIs) which is used to block the enzyme reverse indirectly. Thirdly, 
Protease Inhibitors are used to blocks the action of protease.  
 
1.3.1 Advantages of HAART 
Highly Active Antiretroviral Therapy (HAART) is a treatment that reduces morbidity and 
mortality in PLWHA (Gebo, Keruly and Moore, 2003; Hofer, Schechter and Harrison, 2004; 
Mills et al., 2006; Dieckhaus and Odesina, 2007). HAART is effective in controlling the level of 
the HI-virus to a point where it is no longer possible to detect any HIV in the blood of HIV 
infected individuals. Furthermore, HAART prevents the HIV from multiplying rapidly and it 
boosts the body’s immune system to cope with the HI-virus. As a result ART increases the 
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length and improves the quality of life of patients (Hofer et al., 2004; Carrieri et al., 2006; 
Dieckhaus and Odesina, 2007). In addition, ART treatment enables patients to live full and 
productive lives. The ART treatment brings back hope to the patients once they adhere to 
antiretroviral treatment regimen (Carrieri et al., 2006).  According to Jaffar et al. (2005), many 
African countries decided to introduce HAART in their public health services in order to 
decrease the disease progression and increase their survival.  
 
1.3.2 Challenges to HAART 
According to Roberts (2000), HAART’s regimens are extremely complicated and have strict 
rules regarding as to when the patients must take the drugs. In addition, these antiretroviral drugs 
are demanding with patients being needed to swallow number of pills each day. The ART 
medication is also known in producing side effects. Negative impact about the triple therapy is 
that if HIV infected individual do not use their ART medication as they are expected. Resistance 
to HAART can come about if patients on ART miss doses or take the drugs improperly.  
 
1.3.3 ARV medication initiation 
Department of Health (2003) and National Department of Health (2007) assert that eligibility 
criteria for initiating ARV medication are based on both clinical assessment and CD4 cell count. 
These are the factors that determine whether HIV medication should be started, or be delayed. 
According to WHO (2002) and Southern African HIV Clinicians Society clinical guidelines of 
(2002),   an HIV infected individual must have a CD4 cell count below 200 and/or stage IV 
illness in order to qualify for ART. HIV infected individual who qualifies for ART can access 
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the ARV medication in government clinic and hospitals when considered to be ready to initiate 
medication. Department of Health (2003) strongly emphasized that the decision to initiate 
therapy must therefore be taken not only on meeting the criteria and being ready. However, the 
HIV infected person needs to be committed to adhere to the medication over a long term. WHO 
(2002) recommends that for ARV medication programmes in resource-limited settings, HIV 
infected adolescents and adults should be initiated on ART when they have met one of the 
following criteria:  
WHO stage IV of HIV disease (clinical AIDS) regardless of the CD4+ cells count;  
WHO stage I, II, III of HIV diseases with a CD4+ cell count below 200 cells/mm³; or  
WHO stages II or III of HIV with total lymphocyte count below 1200 cells/mm³.  
The Southern African HIV Clinicians Society (SAHCS) (2002) clinical guidelines 
recommend that patients in the CD4 stratum 200 – 350 cells/mm³ should be started on ARV 
medication.  The SAHCS also point out that starting patients on HIV medication based on 
WHO stage 3 is attractive for resource-poor countries, particularly for those without access to 
flow cytometry for CD4+ lymphocyte count monitoring. From evidence based it is indicated 
that starting HAART at CD4 200 – 350 cells/mm³ leads to a better outcome than at <200 
cells/mm³ (Maartens, 2005).   
 
1.4 Antiretroviral therapy in South Africa 
In November 2003, the National Department of Health in South Africa launched the National 
Operational Plan for Comprehensive HIV and AIDS management, treatment, care, and support 
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(Department of Health, 2003; Department of Health, 2007). This launch was done in response to 
the HIV and AIDS epidemic and the need to ensure that ART is freely available in the public 
health sector (Department of Health, 2003; WHO, 2006; Department of Health, 2007).  It is 
estimated that in 2006 approximately 230, 000 HIV infected patients were receiving ARV at 
South Africa’s hospitals (Actuarial Society of South Africa [ASSA], 2006). Furthermore, ASSA 
projected that 540 000 HIV infected people who were eligible for ART, but they were already 
sick with AIDS not receiving ART (Department of Health, 2007). As a result, the Department of 
Health reviewed the operational plan formulated in 2003 and introduced HIV and AIDS and 
STIs National Strategic Plan (NSP) for South Africa, 2007 - 2011 to reduce HIV and AIDS 
morbidity and mortality as well as its socioeconomic impacts (Department of Health, 2007). This 
review was also done to provide appropriate packages of treatment, care and support to 80% of 
HIV positive people and their families by 2011. The other primary aim of the NSP is to reduce 
the number of new HIV infections by 50%. A drastic transition has been observed after the 
review of the NSP. Evidently, a recent study conducted in South Africa estimated that in the 
middle of 2008, there were 568 000 adults and children receiving antiretroviral treatment 
(Muhammad and Leigh, 2009). Furthermore, the number of adults and children on antiretroviral 
treatment has increased from 4.9% in 2004 to 40.2% in 2008. 
 
1.5 Study Setting 
The proposed study was conducted at Shongwe Hospital, a district hospital situated in Ehlanzeni 
district in Mpumalanga Province. Health services are planned and delivered according to the 
needs of the community based on the principles of the comprehensive primary health care 
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(CPHC) approach (Mpumalanga Department of Health, 2007). Shongwe hospital is one of the 
first sites in Mpumalanga to be accredited (June 2004) to rollout antiretroviral therapy. The clinic 
inside the hospital operates from Monday to Friday from 08H30 hours. In the morning everyday 
starts with a morning prayer and health education planned by the health care providers for 
patients (new and follow-up) in the clinic. Currently, there are more than 3,000 patients on ART 
at the hospital. ART is freely available in the public sector, but the majority of PLWHA who 
qualify for ART start at a later stage when they are already symptomatic. The reason for people 
living with HIV and AIDS to initiate ART late is that they delay to test and discover their HIV 
status. 
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Figure 1: Map of Nkomazi area 
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1.6 Problem statement 
Antiretroviral therapy has been available through public health centres in South Africa since 
2003. Lack of adherence is still a major challenge to AIDS care in sub-Saharan Africa (Hofer, 
2004; WHO, 2006). This “has challenged the abilities of ART services to monitor and retain 
large numbers of patients within the programmes effectively” (Wood et al., 2008: 44). 
Antiretroviral medication has been available to improve lives of HIV infected people however 
many HIV infected people do not adhere to HAART treatment regime as a result it poses a huge 
challenge to  health care system as this brings about highly resistant viruses to HIV treatment. 
The effective delivery of ART requires an understanding of patients’ knowledge, attitudes, and 
beliefs about antiretroviral therapy and their adherence behaviour.  
 
1.7 Organization of the Mini-thesis 
Chapter 2 
The second chapter reports on the literature reviewed for the study. This includes a definition of 
the concept, adherence, non-adherence and poor adherence, measurement of adherence, and the 
factors affecting adherence to antiretroviral therapy.  
Chapter 3 
In this chapter, the aim and objectives of the study are presented. The third chapter articulates the 
research methodology that was used in the study. This chapter further discusses about the study 
design used in the research. Furthermore, study population, sampling and sample size are 
discussed. In addition, data collection and processing, and data analysis explained.  
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The chapter also includes explanation of validity and reliability. This chapter ends with a report 
on the ethical considerations taken in this study. 
Chapter 4 
The fourth chapter reports on the research findings. 
Chapter 5 
In the fifth chapter, the discussion of the research findings is covered. The discussion interpreted 
the current study findings and compared them to the results of similar studies. 
Chapter 6  
The sixth chapter contains the conclusions and recommendations based on the research findings. 
 
 
 
 
 CHAPTER TWO 
LITERATURE REVIEW 
 
This chapter will deal with six themes. Firstly, an explanation of the major terms used in this 
study will be provided. Secondly, a detailed discussion of adherence to antiretroviral therapy and 
ART regimen as well as benefits of adherence to ART medication will be provided. Thirdly, 
description of strategies for measuring of adherence to antiretroviral therapy will be covered. 
Fourthly, factors associated with adherence to antiretroviral therapy are discussed in detail. 
Lastly, this chapter presents conceptual framework of factors associated with adherence to ART. 
 
2.1 Definition of terms 
Knowledge 
Knowledge is defined as the information, understanding and skills that are gained through 
education or experience (WHO, 2006). For the purpose of this study, knowledge refers to how 
ART work and how they should be used. ART is not a cure and that they have to be taken for 
life. 
Attitudes 
According to Coulson, Goldstein and Ntuli (1998), attitudes are described as being a fairly stable 
set of feelings towards a particular issue.  Attitude is also defined as a complex mental state 
involving beliefs and feelings and values and dispositions to act in certain ways (Worchel, 
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Cooper, Goethals and Olson, 2000). For the purpose of this study attitudes toward treatment 
adherence are a person’s evaluative opinions, both positive and negative. 
Beliefs 
Beliefs are defined as a cognitive content held as true (Montgomery, Joseph, Ostrow, Kessler 
and Kirscht, 1989). For the purpose of this study belief refer to confidence that patients on ART 
have in their ability to adhere to their treatment. It further indicates that patients on ART with 
poor belief system give up easily when faced with obstacles and discontinue taking treatment as 
expected, whereas patients on ART with strong belief system would persist when encountering 
obstacles.  
Highly Active Antiretroviral Therapy 
Highly Active Antiretroviral Therapy or HAART is defined as a HIV treatment involving the 
use of a triple combination of antiretroviral drugs (WHO, 2006). 
Antiretroviral therapy 
Antiretroviral Therapy or ART is medication that stops HIV from making new copies of itself 
in an HIV infected patient (National Department of Health, 2004). 
Adherence 
Adherence is described as the ‘extent to which a person’s behaviour- taking medication, 
following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations 
from a health provider’ (WHO, 2003: 3).  The concept, adherence, emphasizes the patient’s 
ability and willingness to take a therapeutic regimen, based on an informed and autonomous 
choice, as determined by a process of shared decision-making between the patient and health 
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care provider (WHO, 2003; Bader et al., 2006). Adherence is also defined as a way of taking 
tablets in all the prescribed doses at the correct time, in the correct doses and in the correct way 
(Roux, 2004; Aspeling, 2006). 
Non-adherence 
According to WHO (2003), non-adherence to medication refers to failure to take medication as 
prescribed, by discontinuing medication before completion of the course, taking more or less 
medication than prescribed, and also by taking dosages at the wrong time. 
Poor adherence 
According to WHO (2001, 2003), poor adherence means that patients are not following the 
prescribed antiretroviral regimens in accordance to time and dietary requirement. 
Therefore, for the purpose of this study non-adherence and poor adherence will be used 
interchangeable.  
 
Social support  
Social support is defined as the attachment among individuals or between individuals and 
groups which improves adaptive competence in dealing with short-term crises and life transitions 
as well as long-term challenges, provisions and stresses (Caplan and Killilea, cited in Moratioa, 
2007). 
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Social capital  
Social capital has been defined as those features of social organization- such as the extent of 
interpersonal trust between citizens, norms of reciprocity, and density of civic associations that 
facilitate cooperation for mutual benefit (Kawachi, Kennedy and Glass, 1999).  However, 
Putman (2000) refers to social capital as connections among individuals including social 
networks and norms of reciprocity and trustworthiness that arise from them. 
 
2.2 Adherence to antiretroviral treatment 
According to World Health Organization (2006), adherence to ART involves an ongoing 
engagement and active participation of an informed patient in a plan of care to adhere to ART. 
Consentual partnership between patient and health care provider, wherein the patients are able 
and willing to make decisions about their medication results in high adherence to ART. The 
good relationship plays an important role in patients’ motivation to adhere to ART and to keep 
their appointments for follow-up because they were part of the treatment plan. Studies by Mehta, 
Moore and Graham (1997) and Bader et al. (2006) refer to the above mentioned partnership as a 
constructive relationship where both parties have a role to play to ensure that support and 
education about the treatment are frankly discussed to sustain adherence. 
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For optimal adherence to ART patients are expected to take more than 95% of their prescribed 
medication over the previous year which is equivalent to missing not more than one dose in a ten 
year period. Adherence to ART includes taking multiple drugs 2 to 4 times a day according to 
strict schedule (Department of Health, 2003). The ART regimen is a strictly regulated treatment 
programme (Machtinger and Bangsberg, 2005; Marais, 2006; Simoni et al., 2006).  
Thus, adherence to medications is crucial for effective therapy. Although, it is complex, its 
dynamic process affects the outcome of antiretroviral therapy and patient’s health status (Horton, 
2000; WHO, 2001, 2006). In addition, Akpomiemie (2005) and Moratioa (2007) suggest that 
adherence can be achieved through commitments of all stakeholders including patient, health 
care providers, family and community to the therapeutic process. Furthermore, Akpomiemie in 
his study conducted in Helen Joseph hospital found that 92.4% of the participants were adherent 
to their ART. 
 
2.2.1. Antiretroviral regimens 
Two regimen are recommended for patients who are ready to commence antiretroviral therapy 
known as first-line regimen 1a and 1b, and second-line regimen 2 (Department of Health, 2003).  
These two ART regimens are mostly utilized in the public health sector. 
Antiretroviral regimen 1a 
According to the National Department of Health (2003), first-line therapy regimen 1a is the 
regimen used for patients who are initiating ART medication. This regimen has been cited as a 
regimen prescribed for all men and women who are able to stick to injectable contraception and 
condoms. Therefore, these man and women start with regimen 1a which consists of stavudine, 
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lamuvudine and efavirenz or stocrine. In this regimen patients are expected to take 5 tablets a 
day (2 tablets in the morning and 3 in the evening). Dennill (2008) said that regimen 1b consists 
of stavudine (d4T), Lamivudine (3TC), and nevirapine for women in childbearing age who find 
it difficult to guarantee reliable contraception while on therapy take 6 tablets a day (3 in the 
morning and 3 in the evening).  This first-line regimen is very potent and has fewer side effects 
than all other regimens. Furthermore, first-line regimen drugs are easier to take than the second-
line regimen. Lastly, this regimen does not need to be kept in a fridge.    
 
Antiretroviral regimen 2 
The second-line therapy regimen 2, is the regimen used for patients who experience incomplete 
viral load suppression or virologic rebound after complete suppression and if viral load above is 
5 000 copies/mm³, despite demonstrated adherence of a patient on ART may be switched to 
schedule 2 (National Department of Health, 2007). The reasons for changing ART to this 
regimen include treatment failure resulted from failure to suppress viral replication with the 
development of viral resistance. Regimen 2 consists of Zidovudine (AZT), Didanosine (ddl), 
lopinavir or ritonavir. The National Department of Health in South Africa recommends that 
patients who have experienced high viral load while on regimen 2 should receive increased 
adherence support. Patients on this regimen are expected to take 6 tablets. The second-line 
regimen has more side effects than first-line regimen. Furthermore, this regimen is more 
complicated than the first-line regimen. Some of the drugs in this regimen need to be kept in a 
temperature below 20ºC so is a challenge for patients on ART who do not have the fridge.  
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2.2.2 Benefits of adherence to antiretroviral therapy 
Adherence to medication is crucial for effective therapy. Therefore, strict adherence is 
considered to be one of the key elements to the benefits of patients’ well being. Studies by 
Chesney (2000),  WHO (2002), Gebo (2003), Coetzee et al. (2004), Hofer (2004), Moore et al. 
(2005), Ware et al. (2005), WHO (2006) and Dickhaus and Odesina (2007) have shown that 
patients on ART are more likely to receive the following benefits when they adhere to their 
antiretroviral medication: 
 Decrease viral load 
 Increase CD4 lymphocyte count 
 Decrease hospitalizations 
 Decrease morbidity and mortality 
 Delayed onset of opportunistic infections 
 Stronger immune system due to delayed progression of disease 
 Longer life-span to fulfil dreams and goals 
 More time to see children grow up and go through life stages 
 Opportunity to convey one’s life experience  
 An opportunity to use the experience of HIV-diagnosis to make life more fulfilling 
 The opportunity to continue earning a living ( i.e. more productive life years)  
 More time to await (and possibly benefit from) the outcomes of scientific research 
 Better quality of life 
 More time to do the things you enjoy. 
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2.2.3 Strategies for measuring adherence to ART 
Studies by Fogarty et al. (2002), Wagner (2002), da Salviera et al. (2003), Roux (2004), Levine 
et al. (2006), Liu et al. (2006), Marias (2006), Simoni et al. (2006) and Dzinza (2007), declare 
that measuring adherence to ART is a difficult activity in both clinical and research setting. 
These authors point that there is a controversy regarding the reliability of current methods used 
to measure adherence to antiretroviral therapy. Nevertheless, a range of strategies for measuring 
adherence have been formulated. Each of these strategies has its own advantages and 
disadvantage. Various strategies used for measuring adherence to antiretroviral therapy include 
patient self reporting, pill counts, electronic event monitoring systems (MEMS), and biological 
and therapeutic drug monitoring (viral load and CD4 counts) (Fogarty et al., 2002; Wagner, 
2002; da Salviera et al., 2003; Roux, 2004; Levine et al., 2006; Liu et al., 2006; Marias, 2006; 
Simoni et al., 2006 and Dzinza, 2007; Thobias, 2008).  
 
Self-reports 
This is the method that relies more on the information provided by the patients about their 
adherence to ART but this has limitations in that patients may not be truthful. According to 
Chesney (2000), patients are requested to reveal information about their adherence to treatment 
in self-report. Furthermore, the data are easily collected and can assist to determine the reasons 
why patients are poor adherents. Patients disclose information about the number of pills that they 
take a day or number of pills they miss in two days and in a week. The dimensions used for self-
reports consists of face to face interviews, questionnaires, calendars and diaries as well as visual 
analogue (WHO, 2006). Self reports have the advantages of low-cost and flexibility of design 
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and data collected can help to determine the reasons for sub-optimal adherence because there is 
no procedure and equipment needed (Chesney, 2000; Liu et al., 2006). Furthermore, self-reports 
are reasonably correct in producing the gist of sub-optimal adherence. Self-reporting has 
however limitations such as overestimation of adherence, due to patients being unable to 
accurately recall missed doses of their treatments.  In self reports patients are more likely to deny 
poor adherence to ART (Chesney, 2000, Liu et al., 2006).  
 
Pill counts  
Pill count involves counting the remaining doses of medication when ART patients visit the 
health facility for his/her scheduled follow up appointment (Chesney, 2000). According to 
Chesney (2000), a pill count provides the health care providers with tangible evidence of poor 
adherence to ART because patients return all pills that were left in the container. Dzinza (2007) 
observed in her study that all physicians used pill counting as a method to assess adherence to 
ART with the patient.  Counting of pills is used in the first three months of initiating ART. This 
method has limitations as physicians reported in the study that patients dump pills so that they 
can be seen as to be complying with treatment. Liu et al. (2006) point out that pill counting is 
time consuming, sometimes is difficult to ascertain because patients are more likely to dump 
pills. Pill counts are also inaccurate to provide indication of poor adherence because patients tend 
to forget the packages or discard them.    
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Medication Electronic Monitoring Systems (MEMS) 
Roux (2004) explains that MEMS caps are a form of measuring adherence whereby a special 
medicine bottle is used with computer chip in the cap. Every time the bottle is opened, it is 
recorded and results can then be downloaded, printed and analysed. Studies have found that, 
MEMS is an objective and accurate measure of adherence to antiretroviral medication (Chesney, 
2000; Liu et al., 2006; WHO, 2006). MEMS also allow detailed view of non-adherence and are 
best correlated with virologic outcomes. Nevertheless, Liu et al. (2006) argue that MEMS has 
limitations such as that it is expensive and a complicated tool to implement.  
Biological and therapeutic drug monitoring  
CD4+ lymphocyte count is extremely important in the assessment of the effectiveness of 
antiretroviral therapy. Dzinza (2007) reports that physicians measure adherence by monitoring 
the CD4 cell counts and viral load. The CD4+ lymphocyte also assists in the assessment of 
immunological failure on therapy. According to World Health Organisation (2002), measuring 
CD4 counts is too expensive to perform and not available in resource constrained areas.  
According to Coetzee et al. (2004), viral load measurements can be utilized as a marker of 
adherence in the first year on ART.  There are, however, limitations in some instances. For 
example, a high viral load does not necessarily indicate poor adherence but that there may also 
be other factors contributing to high viral load.  Despite the limitations of these measurement 
techniques, adherence measures provide valuable insight into the association between drug 
taking and viral load, as well as approaches that may be useful for improving adherence 
(Thobias, 2008). 
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In conclusion, even though there is no single measure gold standard is appropriate for measuring 
adherence to ART.  Various studies are in favour that self-report is mostly utilized measure of 
adherence to antiretroviral medication because of low-cost and flexibility of design. The use of 
more than one measure of adherence allows the advantages of each tool to compensate for the 
disadvantage of the other and to more accurately capture the data required to determine 
adherence levels (Chesney, 2000; WHO, 2006). 
 
2.3 Factors that affect ART adherence  
Constraints to adherence to antiretroviral therapy among historically disadvantaged rural patient 
populations in developing countries are poorly understood (Kagee, Le Roux and Dick, 2007). 
Sustained adherence depends on a multitude of factors, many of which fall outside the patient’s 
immediate control (WHO, 2003). This section will describe several factors that affect adherence 
to ART. These factors will be classified as patient-, socio-economic-, health services-, therapy-, 
illness- as well as community factors.  
 
2.3.1 Patient-level factors 
Patient-level factors that are associated with adherence to antiretroviral therapy include age, 
patient knowledge, level of education, social support, coping skills, attitudes and beliefs, patient 
forgetfulness (WHO, 2006; Mills et al., 2006a; Mills et al., 2008). These factors seem to be 
impacting negatively on patient’s ability and motivation to adhere to medication. 
 
 
 
 
 
 23 
 
Age  
Studies by Mehta, Moore and Graham (1997), Gordillo, del Amo, Soriano and González,-Lahoz 
(1999) and Chesney (2000) that younger individuals struggle to comply with treatment because 
of dependence to their caregivers to administer their medication. According to Naar-king et al. 
(2006), children and adolescents with HIV may experience difficulties to take their medication 
because their families’ desire for secrecy about their illness. Families with children who are 
HIV-infected prefer to keep the child’s HIV status as secret because they are afraid of being 
severely stigmatized, discriminated and rejected as a result children struggle to adhere to 
medication (Hammami, Nostlinger, Hoerée, Lefèvre, Jonckheer and Kolsteren, 2004). 
 
Patient knowledge 
Non-adherence among patients on ART has been found to be significantly associated with the 
patient not knowing the correct dose of medication (Mehta, Moore and Graham, 1997). The 
authors also report that patients’ lack of knowledge of their diagnosis and expected course of 
their illness or medications has also been associated with decreased adherence. Nevertheless, 
patients who learned the names of their medications were cited to be adherent than those who did 
not know the medication names. 
 
Level of Education  
Low level of education was found to be associated with poor adherence and may impact 
negatively on some patient’s ability to adhere, while a higher level of education has a positive 
impact to medical treatment (Gordillo et al., 1999; Kalichman, Ramachandran and Catz, 1999; 
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Heath, Singer, O’Shaughnessy, Montaner and Hogg, 2002; Pinherio et al., 2002; Reynolds et al., 
2004; Hofer, Schechter and Harrison, 2004; Kagee, Le Roux and Dick, 2007; Falagas, 
Zarkadoulia, Pliatsika and Panos, 2008). Patients experience difficulties to follow physician, 
nurse and other health workers instruction on taking treatment. Patients on ART with low level 
of education/knowledge struggle to follow instructions because of difficulties in recognizing 
correctly their current medications (Pinheiro et al., 2002). This has an impact on PLWHA to take 
their treatment as they are informed by the health care providers in the health facility. These 
authors also report that self-efficacy about antiretroviral therapy was found to be extremely high 
in ART patients with more years of schooling in Brazil. The greater prevalence of adherence 
among patients with more years in school was reported because increased level of education 
provided the patients with skills such as planning, organizing and integration  
 
Social Support  
Research has shown that consistent support from family members and significant others is a 
strong indicator of medical adherence (Chesney et al., 2000; Bearman and La Greca, 2002; 
Simoni, Frick, Lochkart and Liebovitz, 2002; Attawell and Mundy, 2003; Hofer, Schechter and 
Harrison, 2004; Skhosana, 2006; Kagee, Le Roux and Dick, 2007). Family members who openly 
provide social support to patients on ART increases probability that the patients will disclose 
their HIV status and adhere to antiretroviral treatment. Social support provides motivation and 
encourages adherence to therapy as well as promoting other healthy behaviours.  Whereas, Van 
Dyk (2001) and Timmons and Lynch (2004) pointed out that some people living with HIV/AIDS 
receive positive support from their loved ones, others are discriminated against, rejected and 
isolated from their families. That is why the authors referred to these kinds of experiences as a 
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“double-edged sword” because they break or build up a person’s motivation. It is reported that 
problems in relationships such as rejection by sexual partners, family members, friends, and 
community members are often experienced by PLWHA after disclosure, which can deter them 
from taking treatment openly (Qwana, Mkaya, Dladla and Lurie, 2000; Nachega et al., 2005; 
Toivo, 2005; Mills et al., 2006a). This has devastating impact on patients on ART when they are 
expected to comply with treatment. According to Attawell and Mundy (2003), buddy support 
and support groups play a crucial role in HIV medication compliance.  
 
Coping skills 
ART patients have a tendency to mix different forms of treatment including faith based healing, 
alternative and conventional medicine and traditional medicine (Van Dyk, 2001; Aidsguide, 
2006 cited in Marais, 2006). Bader et al. (2006) found that the majority of the women use 
prayers as a coping skill because of the belief that they might be healed from the illness. Dzinza 
(2007) reports that physicians in her study were concerned about the information spiritual leaders 
gave to their patients such as advising the patients to stop taking ART as they would pray for 
them and cure the disease. Dzinza (2007) also report that physicians were concerned about the 
negative effect of herbal treatment to adherence of ART. The implication of herbal medicine in 
patients who are taking ART is that it affects the interaction of treatments at the end results to 
sub-optimal adherence. This seems to be impacting negatively on patients’ adherence as some 
patients seek help from traditional healers whilst they are already on ART. 
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Attitudes and beliefs 
Reynolds et al. (2004) describe beliefs as the level of confidence that patients have in their 
ability to adhere/comply with treatment. In this regard, a strong belief in one’s ability to adhere 
to antiretroviral therapy could potentially enhance the patient’s capacity to comply with 
therapeutic regimen. According to World Health Organisation (2001), (2006) and Mills et al. 
(2006a) patient’s beliefs about their illness and effectiveness of medication are predictive of 
adherence. A good level of understanding about HIV by the patient, a belief that antiretroviral 
therapy is effective, and prolongs life, recognition that poor adherence may result in viral 
resistance and treatment failure. All these beliefs impact negatively upon a patient’s ability to 
adhere to ART (Montgomery et al., 1989; Mehta, Moore and Graham, 1997; WHO, 2001; 2006). 
These authors also argue that the patients’ acceptance of the disease and perceptions about the 
benefits of the treatment influences their adherence behaviour. According to Becker (1974), and 
Pinheiro et al. (2002), beliefs in personal abilities govern the health behaviour which is 
adherence to antiretroviral therapy.  
 
Patient forgetfulness 
Patient forgetfulness cited as a barrier to adherence to ART (Roberts, 2000; Reynolds et al., 
2004; Marais, 2006; Mills et al., 2006a, WHO, 2006; Dieckhaus and Odesina, 2007, Wang and 
Wu, 2007; Amberir et al., 2008; Thobias, 2008; Malangu, 2008).  These authors mentioned that 
patients on ART simply forget to take treatments due to being away from attending social events 
such as night vigil, funerals, weddings and parties.  
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2.3.2 Socio-economic factors  
Socioeconomic factors such as social habits and lifestyle, financial constraints, and poverty are 
found to be barriers to adherence to ART (Louw, Van Ede and Louw, 1998, da Salviera et al., 
2003; WHO, 2006, Falagas et al., 2008). 
 
Social habits and lifestyle 
Active alcohol consumption and drug abuse have been cited to be associated with poor 
adherence to ART (Golin et al., 2002, Golin et al., 2004; Mills et al., 2006b; WHO, 2006).  
These authors report that alcohol, and drug abuse is impacting negatively to adherence as they 
lead patients to forget not to take their HIV medication. Furthermore, these factors increase the 
possibility of patients to engage in unhealthy risk behaviours.  
 
Financial and distance constraints 
Studies by Pinheiro, de Carvallo-Leite, Drachler and Silveira (2002), Attawell and Mundy 
(2003), Marais (2006), Moratioa (2007), Mills et al. (2006a) and Uzochukwu, Onwujekwe, 
Onoka, Okoli, Uguru and Chukwuogo (2009) show that financial resources to travel to health 
facilities for patients in order to collect their ART are challenges resulting in patients missing 
their follow-up appointments. Specifically, it is not easy for patients in rural areas to have access 
to the health facilities because of the poor roads, long distances and the cost of the transport 
(Jaffar et al., 2005; Popa-Lissenanu et al., 2005).  Various studies in developing countries 
revealed that living in economically disadvantaged and resource-limited contexts contribute to 
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poor adherence amongst patients who are on ART. According to Weiser et al. (2003) and WHO 
(2006), patients on ART travel long distances to health facility cited as a significant barrier to 
adherence to antiretroviral medication. Some patients in Botswana mentioned that they lived 800 
to 1000km away from the clinic and had to travel that distance on monthly basis (Weiser et al., 
2003). The long distances negatively impacting on patients to comply with ART.  
According to World Health Organisation (2006) and Falagas, Zarkadoulia, Pliatsika and Panos 
(2008), economic support has been cited as directly related to the level of adherence to ART. For 
example, in a cross-sectional study in Brazil Gordillo et al. (1999), observed that there was better 
adherence to ART medication among patients on ART who were having sustainable occupation 
and chances of them to follow ART instructions were high.   
 
Poverty 
Poverty does not operate on its own as a risk factor for adherence to antiretroviral therapy. 
However, there are poverty-related stressors arising from aspects of poverty in disadvantaged 
areas such as inadequate food and unemployment have been shown to be associated with poor 
adherence. Lack of food has been cited as a problem in Uganda, Botswana and Tanzania for 
most patients on antiretroviral therapy. Unemployed patients who are on ART seriously lack 
food as a result suffers from hunger and they are unable to satisfy their increased appetites 
stimulated by their medication (da Salviera et al., 2003; Kalichman, Simbayi, Kagee, Toefy and 
Jooste, 2006; Marais, 2006; WHO, 2006; Moratioa, 2007; Spies, 2007; Thobias, 2008). This 
means that patients on ART stop taking medication due to shortage of food in the household. In 
addition, lack of food disrupts the daily schedule for taking medication and negatively influence 
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adherence (Thobias, 2008). Hunger seems to be a profound problem to patients on ART because 
it disrupts the process of medication absorption in the body (Larkin, 1998; Bukusuba, Kikafunda 
and Whitehead, 2007).  
 
2.3.3 Health-services factors 
Health service factors that affect adherence to antiretroviral therapy include doctor-patient 
relationship, quality care, lengthy waiting times and distances to health facilities and follow-up 
schedules (WHO, 2006). These factors are explained.  
 
Health provider-patient relationship  
According to Chesney (2000), World Health Organisation (2006) and Marais (2006), doctor-
patient relationship predicts the success and failure of antiretroviral medication among the 
patients taking the medication. In this relationship patient’s involvement as an active member is 
crucial in the process of decision-making during discussion of treatment options and information 
exchange so that patients on ART will adhere to their treatment (Cassidy 1999; Bader et al., 
2006). Involvement of patients in decision making makes the patient to have trust in the health 
provider and clinic staff and builds satisfaction (Barker et al., 2004). If the relationship is build 
on the foundation of respect and effective relationship such as warmth, openness and cooperation 
chances of adherence are high. In other cases health providers ill-treat patients on ART 
inhumanely calling them by names, like “cattle or a number” and “guinea pigs” (Remien et al., 
2003).   
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Quality care 
Health care workers with a poor understanding of dynamics of adherence and patients reduce the 
quality of care patients on ART. This has a negative impact on the quality care delivered to 
patients on ART as the health care workers might not be able to identify clients with poor 
adherence.  Shortage of staff is a major constraint to quality care and results in overworking of 
the available staff. This is also a serious problem because it leads to inability or unwillingness to 
engage the patients who are on ART in the planning and management of quality care.  
 
Waiting times in health facilities 
The problem of long waiting times was mentioned as a major challenge to adherence among 
patients who are on ART in Botswana, Tanzania and Uganda (WHO, 2006). Patients spent an 
average time of five hour while waiting for consultation and medication. Prolonged waiting 
times have negative effect on both follow-up appointments and adherence (Dehab et al., 2008). 
The World Health Organisation recommended that health facilities should avoid keeping patients 
waiting for long period of time waiting for consultation and medication in order to maintain high 
adherence levels over a long period.   
 
Attitudes of health care providers 
Thobias (2008) notes that patients have often mixed attitudes about the health care providers. 
Thobias further reports that there were patients who were generally satisfied with the behaviour 
of the health care providers; others however, were completely dissatisfied with their attitudes. 
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Follow-up schedules 
Appointment dates have been cited as a key challenge for patients on ART to adhere to their 
medication (Spies, 2007; Thobias, 2008). This is a challenge to patients because of their inability 
and unwillingness to contribute in decision making about their medication.  
 
2.3.4 Therapy-related factors 
Therapy-related factors include a number of pills and side effects. These factors were reported to 
be associated with devastating impact to adherence to ART (da Silveira, de Lourdes Drachler, de 
Cartalho Leite and Pinheiro, 2003; Wang and Wu, 2007; Roberts, 2008). 
 
Number of pills      
High pill burden and frequent doses have a negative impact to adherence to ART because 
patients on ART struggle to comply with the complicated regimen (Roberts, 2000; Pinheiro et 
al., 2002; Popa-Lissenanu et al., 2005; Mills et al., 2006a; Uzochukwu, Onwujekwe, Onoka, 
Okoli, Uguru and Chukwuogo, 2009). In a qualitative study among a diverse sample of HIV 
positive men and women in four U.S. cities most of the respondents expressed that their 
medication were irritating and challenging (Remien et al., 2003). Hammami, Nostlinger, Hoerée, 
Lefèvre, Jonckheer and Kolsteren (2004) and Nachega, Stein, Lehman, et al. (2004) report that 
medication related factors such as volume, taste, diet prescriptions, intake pills, strict timing of 
doses, and side effects are difficult to overcome. The participants in a qualitative study in 
Belgium were concerned about the number of pills, the frequency of the doses, size and the taste 
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of the pills. Literature on HIV antiretroviral and treatment adherence indicates that patients with 
prescriptions of three to four daily doses were 53 % less likely to comply with treatment than 
patients who had been prescribed a two-dose regimen (da Salviera et al., 2003). 
 
Side effects 
Marais (2006) comments that all forms of adverse effects influence patients on ART from 
adhering to their treatment. The side effects include nausea, diarrhoea, headache, rash, vomiting, 
and sleep disturbance. These adverse effects have profound impact to adherence to antiretroviral 
medication, activities of daily as well as obligations and quality of life (Gordillo et al., 1999; 
Roberts, 2000; Heath et al., 2002; Remien et al., 2003).  
 
2.3.5 Illness-related factors 
Illness-related factors that influence adherence to antiretroviral therapy such as depression, 
stress, and anxiety were reported to be associated with adherence. 
 
Depression, stress and anxiety 
Emotional and psychological distresses are commonly associated with decreased adherence in 
HIV infected patients (Mehta, Moore and Graham, 1997; Thobias, 2008). Research shows that 
there is a strong relationship between adherence and depression (Ciechanowski, Katon and 
Russo, 2000; Mills et al., 2006a).  Major depression is commonly cited psychiatric problem 
among HIV infected individuals with prevalence rates ranging from 17 to 30% (Mehta, Moore 
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and Graham, 1997). Studies have shown that depressive syndromes are the most prevalent 
mental disorders related to HIV infection (Pinheiro et al., 2002; Starace et al., 2002). Depression 
has been cited as having negative effect on the quality of life of PLWHA and is associated with 
poor adherence to HIV treatment (Reynolds et al., 2004; WHO, 2006). Depressive symptoms 
that patients on ART experience are social withdrawal, occupational dysfunction, sexual 
rejection as well as restriction in the activities that give meaning to life, loss of physical and 
financially independence and uncertainty about the effectiveness of ART.  
 
2.3.6 Community factors 
Community factors consist of problems such as stigma and discrimination. These problems have 
been cited as impacting negatively to adherence to ART medication (WHO, 2006; Department of 
Health, 2007). 
 
Stigma and discrimination  
Most of HIV positive patients decide to not disclose their HIV status, reasons being that they fear 
stigmatization, discrimination and isolation (Mills et al., 2006a; Department of Health, 2007; 
Thobias, 2008; Uzochukwu, Onwujekwe, Onoka, Okoli, Uguru and Chukwuogo, 2009). This has 
an impact on patients who are supposed to take their treatment in public places; therefore coping 
with the secrecy is difficult because they are depriving their rights to ART medication. When 
patients on antiretroviral therapy experience difficulties end up hiding everything related to their 
medication (WHO, 2006). The problem of stigma and discrimination forces HIV infected 
patients to engage in high-risk behaviour that affects adherence (Qwana et al., 2000). According 
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to Thobias (2008), negative attitudes and discriminating behaviours towards patients on ART in 
Namibia includes gossiping, avoidance, isolation, labelling and rudeness.  
 
2.4 Summary  
The factors that influence adherence to antiretroviral therapy (patient, socioeconomic, health 
service, therapy, illness, and the community), identified in the preceding literature review can be 
summarised by conceptual framework (Figure 2) below. These six groups of factors interact 
resulting in poor adherence to antiretroviral therapy among patients, and form the conceptual 
basis for the current study.  
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Figure 2: Factors leading to poor adherence to ART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOCIOECONOMIC 
FACTORS 
HEALTH SERVICES 
FACTORS 
THERAPY 
FACTORS 
ILLNESS 
FACTORS 
PATIENT 
FACTORS 
POOR 
ADHERENCE 
Socioeconomic 
Status 
 Social habits 
 Lifestyle 
 Financial 
 Poverty 
 
 
Poor Supports 
 Doctor/Patient  
 Quality care 
 Attitudes  
 Poor communication 
 Follow-up 
 Poor roads 
 Long distance/waiting 
  
 Pill burden 
 Side Effects 
 Frustration 
 Dissatisfaction 
 
 Depression 
 Emotional 
 Anxiety 
  
Age 
Education 
 Social Support 
Coping 
Skills 
Attitudes  
Beliefs 
Knowledge 
COMMUNITY 
 Stigma 
 Discrimination 
 
 
 
 
 CHAPTER THREE 
METHODOLOGY 
 
In this chapter, a description of the aim and objectives of the study is covered.  This section 
covers the study design, study population, sample size, sampling procedure, data collection and 
processing, data analysis, validity, pilot study and reliability, as well as ethical considerations. 
 
3.1 Aim and objectives of the study 
The aim of the study was to assess the factors associated with poor adherence to antiretroviral 
therapy including knowledge, attitudes and beliefs to ART among people on ART at Shongwe 
hospital. 
 
The objectives of the study were to: - 
 describe knowledge, attitudes and beliefs about of patients on ART; 
 describe the levels of adherence amongst patients on ART using 2-day and 7-day recall; 
 describe social support and coping skills of patients on ART;  
 describe health services factors that may influence adherence to ART; and 
 analyse associations between self-reported adherence and various patient, social capital and 
health services factors. 
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3.2 Study Design  
A descriptive, cross-sectional survey aimed at describing the knowledge, attitudes, beliefs and 
adherence behaviour of PLWHA to antiretroviral treatment (ART) at Shongwe Hospital in 
Nkomazi region in Mpumalanga province, South Africa was conducted. A descriptive study was 
chosen in order to describe the phenomenon of interest and observed associations in order to 
estimate certain parameters (Bowling, 1997).  According to Couglan, Cronin and Ryan (2007), 
Vaughan and Morrow (1989) and Beaglehole, Bonita and Kjellström (1993), descriptive cross-
sectional surveys are useful to measure the relationship between two or more variables, and 
analyse significance of statistical associations.  
 
3.3 Study population 
The study population consisted of patients (males and females) who were on ART for at least six 
months, between the ages 15 and 65 years, and registered in the HAART programme at the 
Shongwe hospital. There were 3,000 people on the register for ART by mid 2008.  
 
3.4 Sampling Procedure 
Burns and Grove (2005) describe eligibility criteria or inclusion criterion as a list of 
characteristics essential for eligibility in the study population.  All patients on ART meeting the 
eligibility criteria of the study were randomly selected to ensure that every patient on ART has 
an equal chance of being selected for the study (Wegner, 2007). Participants were identified for 
the study from the ART register of the hospital using simple random sampling. This was done to 
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avoid bias.  A number was assigned to each name on the list e.g. 1 to 3000. Numbers were 
written on a piece of paper; all the papers were folded and put in a box. 184 papers were taken 
out of the box (by a neutral person) and the numbers were recorded as a sample for the study. 
 
3.5 Sample Size 
The sample size for the study in order to obtain an estimated proportion of 95% confidence level 
was estimated using the StatCalc design in Epi-Info version 3.4.1. The estimated total number of 
patients on ART in Shongwe hospital at the time of study was 3000. This was based on the 
assumption that 20% of the patients achieve optimal adherence to ART. Using the StatCalc in 
Epi-Info version 3.4.1 (with expected rates of 20% and worst acceptable estimate 15%) the 
sample size was estimated to be 184. 
 
3.6 Data Collection  
A permission to conduct the study was obtained from the Mpumalanga Department of Health 
Provincial Research and Ethics Committee (Appendix 2). The acting Chief Executive Officer 
and Medical Manager of Shongwe hospital were also furnished with the letter of approval from 
the Provincial Research and Ethics Committee. The purpose of the study was explained to the 
participants of the study and the consent was signed before completion of the questionnaires. 
Participants were also informed about their right to withdraw from the study and issues of 
confidentiality were explained. The researcher assisted participants who were struggling with 
writing when completing the questionnaires. Participants were allowed to ask for clarification 
from the researcher at any point in the completion of the questionnaire. The questionnaire was 
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administered from the 2
nd
 of March to the 17
th
 of March 2009. The questionnaire was translated 
to the local language (siSwati) of the participants.   
 
The questionnaire was a method of gathering self-reported information from respondents through 
self-administration and face-to-face interview. Furthermore, this method of data collection 
involves respondents in conversation (Bless and Higson-Smith, 2000; Leedy and Ormord, 2005). 
A previously validated questionnaire about antiretroviral treatments and people living with HIV 
was adapted to suit patients on ART for the study (Godin, Gagné and Naccache, 2003; WHO, 
2006b; WHO, 2008). Validated questions from the 1998 South African Demographic and Health 
Survey were also included (Department of Health, Medical Research Council and Macro 
International Incorporated, 1998). The questionnaire consisted of four sections, namely 
demographic characteristics, social support, knowledge, attitudes and beliefs about ART as well 
as health services (Appendix 5).  
The coded questionnaire was piloted among patients on ART, and then adjustments were made 
before final implementation of the study. Patients on ART were approached about participation 
in the study while waiting for their appointments in the waiting rooms of the clinic. 
Questionnaires were checked and completed on site before the interviewer departed. 
Questionnaires were checked for errors before a patient on ART was released after questioning 
and any errors made were immediately corrected. 
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3.7 Data Analysis 
Quantitative data was analysed using the SPSS version 16.0 and for stratification Epi-Info 
version 3.4.1 software was used. In addition, data was numerically captured twice in separate 
files using Microsoft excel program. It was then imported to the SPSS 16.0 version 2007 for 
further analysis with the help of the statistician. Completeness: all data collected with the 
questionnaires was checked before it was entered into the SPSS 16.0 and Epi-Info 3.4.1 
software. Proper Place: the data was often checked to see if it had been correctly entered in the 
correct item blocks or lines as the data could easily entered in the incorrect place. The questions 
in the questionnaire to map the data based on numerical and categorical.  Statistical analysis that 
was followed in the study includes three essential steps in data analysis. Firstly, each variable 
was analysed separately, one after the other, for the distribution of counts in each category. For 
the numerical data such as age, hours spent in the hospital, minutes spent while waiting to be 
attended, and total number of pills missed as well as the total times pills missed were analysed. 
These numerical data were analysed to obtain means, range, and standard deviation. All 
categorical data were analysed to produce the frequency distributions. The one-way tabulation 
was performed to inform the researcher about the responses from the participants.  
Secondly, analyses were done on pairs of variables that were relevant and stratified according to 
such variables as age, gender, education and economic status. This cross-tabulation was 
produced to show any associations from the findings.  
Thirdly, calculations were done to obtain adherence rates and dichotomized into two categories, 
namely ≥ 95% (optimal) adherence and ≤ 95% (sub-optimal) adherence. These categories were 
also analysed to understand the associations. Adherence measured through self-report only 
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reflected the adherence over the period of recall (e.g. 2 days and 7 days). The formula used to 
calculate adherence level: 
                
% Adherence =    
# of doses patient should have taken – # of doses missed  
X 100                   
                                           # of doses patient should have taken 
 
Further analysis were done by looking for associations between gender related to knowledge 
about ART, gender related to employment status, level of education related to knowledge about 
ART, health services related to gender variables and to check whether any apparent differences 
were significant or not.  The statistical significance was assessed at p<0.05 level. This helped to 
rule out one important threat to validity and the result could be due to chance rather than to real 
difference (Couglan, Cronin and Ryan, 2007). Data is presented using tables, pie charts, bar 
charts and box plots. 
Independent t-tests between <95% adherence and ≥95% adherence and time spent during last 
visit to health service, and waiting time. 
 
3.8 Validity  
Face validity is the appearance of the questionnaire (De Vos et al., 2005) and content validity is 
the validity is content particular construct an appropriate strategy concerned with a test’s ability 
to include or represent the entire construct (Burns and Groove, 1993; Rungtusanatham, 1998). 
Furthermore, content validity is based on the extent to which a measurement reflects the specific 
intended domain of the content. This approach assumes that a good detailed description of the 
content domain. Health care providers at Wellness clinic were provided with a sample 
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questionnaire so that they could assess its validity. The inputs from the consultation with the 
health workers assisted in rephrasing of the questions. The questionnaire was compiled in 
English then translated into siSwati as the first language of the most study population. The 
questionnaire was found to be relevant by the health care providers to the context of Shongwe 
hospital.   
 
3.9 Pilot study 
A pilot study was conducted prior to the collection of the main of the data of the study to test the 
construct of the questionnaire. This was done to test whether participants understood the 
questionnaire and completed it comprehensively. In addition, pilot study was conducted to 
determine the content validity of the questionnaire and identify changes needed before they were 
administered. 
 
3.10 Reliability 
Instrument bias was reduced by using structured questionnaires adapted from Casey (2004) and 
Godin, Gagné and Naccache (2003). Furthermore, assistants were trained in the administration of 
the questionnaire before the beginning of the study to ensure standardization and to avoid 
misclassification. Reliability was enhanced by ensuring that questions were asked according to 
the set order on the questionnaire. Similarly, the researcher and assistants did not expand and 
probe more than it was anticipated in the questionnaire. A pilot study was conducted to test the 
instrument for further adjustment to avoid ambiguity. The findings of the study were generalized 
to the study population.  It was ensured that the method used for data collection was reliable so 
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that there would be repeatability in order to produce the same results. This would help with 
consistency of the same information of patients on ART in Shongwe hospital. Nonetheless, it 
was anticipated that the findings would have relevance more broadly to the needs of patients on 
ART. 
3.11 Ethical Considerations 
Burns and Grove (1993) point out that conducting the research ethically goes from the 
identification of the research topic to the publication of the study results. An application for ethics 
approval was submitted for approval, and then was accepted by the University of the Western 
Cape Ethics Committee and Higher Degrees Committee (Appendix 1). Permission was obtained 
from the Mpumalanga Provincial Research Ethics Committee Department of Health and Shongwe 
Hospital for ethical approval (Appendix 2). Participation in the study was voluntary for all patients 
on ART. The participants were provided with a letter explaining the purpose of the research study 
requesting their participation and assuring them confidentiality (Appendix 3). Participants gave 
informed consent to participate in the study. Furthermore, the participants had the right and 
opportunity to withdraw from the study at anytime. A consent form used to for participants 
(Appendix 4) was given and attached to the questionnaires and signed by the participants after the 
study had been fully explained to them.  The participants’ right to anonymity was observed by 
using numbers instead of respondents’ names, as confidentiality would be assured during 
dissemination of results. Respondents were informed that no harm or benefits could be expected 
from the study, as it was being conducted for academic purposes. Furthermore, the respondents 
were protected no physical, emotional or social harm was caused to participants. Respondents 
were informed in advance that participation in the study is voluntary and they may withdraw at 
any stage.  
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 CHAPTER FOUR 
RESULTS 
 
In this chapter, the results of the study are presented. The first section contains a description of 
the study sample. Thereafter, the results from the findings will be presented according to the 
objectives of the study. Subsequently, statistical analysis will be covered in order to explore the 
associations between different factors and adherence levels to ART. 
 
4.1 Description of study participants  
A total of 184 questionnaires were completed by patients on ART receiving their medication at 
Shongwe hospital, Mpumalanga Province (Table 1). The mean age of participants was 38.9 years 
with a standard deviation of 10.27 years. The median age was 37.5 years, with a minimum age of 
16 years and maximum age of 65 years. The majority of the participants (71.2%) were females. 
Slightly more than half of the participants (54.9%) were single, while 23.9% reported being 
married or living with a partner. More than half of the participants (54.3%) had secondary 
education and 2.2% had tertiary qualifications. Less than one in five participants (16.3%) 
reported that they were employed. Of those participants who were employed, half (16/30) earned 
more than R1000 per month.  
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Table 1: Demographic characteristics of participants (N=184) 
Variable                                       N (%)                Mean (Standard Deviation)          
Age (in years)                          ___                                             38.9 (10.27) 
         15 – 40                               113 (61.4) 
         40 – 65                                 71 (38.6) 
Gender 
       Male                                       53 (28.8) 
       Female                                  131 (71.2) 
Marital Status 
        Single                                   101 (54.9) 
        Married/Cohabitation             44 (23.9) 
        Widowed                                30 (16.3) 
        Divorced/Separation                 9 (4.9) 
Education 
       No schooling                             20 (10.9)                              
       Primary School                         60 (32.6) 
       Secondary  School                  100 (54.3) 
       Tertiary                                       4 (2.2%)                                          4 (2.2) 
Employment status  
         Employed                                30 (16.3) 
         Unemployed                          154 (83.7)                          
 
4.2 Knowledge about antiretroviral therapy  
4.2.1 Knowledge about Regimen  
When participants were asked to indicate the name of the ART regimen they were on, all 
participants could name their regimen and describe the correct methods of taking their 
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medication. Most participants (65.6%) were on Regimen 1a, which consisted of 
lamivudine/stavudine/stocrine or efivarenz; a third (34%) of participants were on Regimen 1b, 
taking the lamivudine/stavudine/nevirapine combination; and no participants were on Regimen 2 
(lamivudine/stavudine/kaletra) (Table 2). These ART regimens had dosing schedules of two 
doses a day and 5 – 6 pills per dose. Most participants (71.7%) reported that they suffered from 
side effects upon initiation of ART.   
Table 2: Regimens of antiretroviral therapy by gender 
 Female Male                                                                   Total
Regimen 1a 67 53 120 
Regimen 1b               63 0 63 
Regimen 2          1 0 1 
 
4.3 Knowledge and beliefs about Antiretroviral Therapy  
Knowledge about ART in this study was classified into two categories: knowledgeable (correctly 
answered the entire questions = 100%) and poor knowledge (incorrectly answered some of the 
questions less than 100%). Knowledge about ART was rated using 12 questions worth one point 
each. About 55.7% (102/184) participants obtained a score of 100% suggesting that they were 
knowledgeable about antiretroviral therapy (ART), while less than half 44.3% had poor 
knowledge. All participants reported that they believe that ART is effective, and that it could 
improve their quality of life. Knowledge of the importance of adherence was shared among all 
participants as they correctly indicated that missing doses of ART leads to disease progression. A 
small proportion (23.9%) of participants, though, erroneously believed that HIV can be cured 
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with ART. A further 20.3% of the participants did not believe that ART can prevent transmission 
of HIV from mother to child. More than half of the participants (53.3%) believed that ART is 
harmful to their body. Most (92%) participants correctly identified that ART has side effects.  
Almost all participants (98.4%) believed that taking ART prevents disease progression. 
However, small minorities of the participants did not believe that missing doses of ART 
increases the risk of transmitting (3.3%). All the participants reported that they did not believe 
that traditional medicine is more effective than HIV medication (Table 3).                        
Table 3: Knowledge and beliefs about antiretroviral therapy  
                                                                              Total                        Female                 Male 
ART prevent to mother to child transmission     146 (79.3%)            114 (87%)               32 (60.4%)              
HIV can be controlled by ART                           180 (97.8%)            128 (97.7%)            52 (98.1%) 
ART is effective and prolongs life                      184 (100%)             131 (100%)             53 (100%) 
HIV can be cured by ART                                   140 (76.1%)           100 (76.3%)            40 (75.5%)  
Taking ART prevents disease progression           181 (98.4%)           130 (99.2%)           51 (96.2%)                 
 Not starting ART when indicated can make  
        you sick                                                          184 (100%)             131 (100%)          53 (100%)               
ART improves quality of life                                 184 (100%)             131 (100%)          53 (100%)                   
Antiretroviral medicine can cause side effects     171 (92.9%)             123 (93.9%)          48 (90.6%) 
Missing doses of ART leads to disease  
Progression                                                              183 (99.5%)            130(99.2%)          53(100%) 
Missing doses of ART increases the risk of  
    transmitting HIV                                            178 (96.7%)               127 (96.9%)            51 (96.2%)               
Believe ART is harmful to your body                       98 (53.3%)            67(51.1%)             31(58.5%) 
Believe traditional medicine is more effective  
     than prescribed medication                               184 (100%)         131(100%)                53(100%) 
Total                                                                        102/184 (55.7%)  
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4.4 Self reported Adherence  
4.4.1 Two-day recall 
Most (92.4%) participants reported optimal adherence taking more than 95% of their pills as 
prescribed to ART over the last two days (Figure 3). A small proportion (4.3%) of participants 
reported missing two pills over the past two days (3.3%) participants mentioned that they missed 
3 pills. This translates to sub-optimal adherence taking less than 95% of the ARV medication. 
4.4.2 Seven-day recall 
Most (84.2%) participants reported optimal (≥ 95%) adherence to ART over the past seven days 
(Figure 3). However, there was a small proportion of 15.8% (29/184) participants reported sub-
optimal (<95%) adherence to ART (Figure 3).  
 
Figure 3: Self-reported adherence to antiretroviral therapy 
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4.4.3 Barriers to adherence to antiretroviral therapy 
Small proportion (15.8%) of participants reported experiencing barriers to follow the ART 
regimen. The most frequently cited barriers were problem with travelling to the clinic 41(22.3%), 
forgetting to take ART medication 36(19.6%), sleeping away from home 34(18.5%), visiting 
bars 14(7.6%) and the daily routine/work (1.6%) (Figure 4).  
 
 
Figure 4: Barriers to adherence 
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4.5 Social capital 
4.5.1 Disclosure of HIV status and being on antiretroviral therapy  
Disclosure of HIV status was high among the respondents, with 97% having disclosed their HIV 
status. Participants reported that they disclosed their HIV status to family members which 
include siblings 49.5% (91/178), parents 45.1% (83/178), grandparents 5.45% (10/178) and 
aunt/uncle 9.8% (18/178). Surprisingly, less than half 42.4% (78/178) of the respondents 
reported that they disclosed their HIV status to their partner (Figure 5).  
 
 
 
Figure 5: Disclosed HIV status  
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Almost all (97.3%) participants reported that they disclosed being on ART to someone. The 
majority (97.7%) of female participants reported that they disclosed being on antiretroviral 
medication (Figure 6). Interestingly, most (96.2%) of male participants indicated that they have 
disclosed being on ART.  
 
 
 
 
Figure 6: Disclosure of being on antiretroviral treatment 
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4.5.2 Fear of discrimination 
Forty-three participants (23.4%) indicated that they fear discrimination from friends, partners 
(6.6%) and family (13.6%), if they discover that they are on ART (Table 4). 
                                     
4.5.3 Financial support 
It was observed that 83.7% (154/184) of the participants who were unemployed and did receive 
financial support of any kind; 19.6% reported that they received financial support from their 
family, 69% received social grants, 30.4% child grants and only 0.5% unemployment grants 
(Table 4). Twenty-one percent female participants reported that they were receiving financial 
support from their family, whereas 8(15.1%) male participants also mentioned that their family 
support them financially. The majority (83.7%) of unemployed participants stated that they relied 
on the government for financial support.  
Psychosocial support 
Only a small proportion 26.1% (48/184) of the participants participated in support groups in their 
community. 
 
4.5.4 Social activities 
Only a small proportion (11.4%) of the participants reported that they participated in leisure 
activities (watching soccer at the local sport grounds) during the previous seven days, and 7.6% 
reported having visited a bar in this period (Table 4). Only 66 participants (35.9%) stated that 
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they visited friends or family, whereas less than half (40.8%) received visits from friends or 
family. A small proportion (10.9%) of participants reported eating out at a restaurant, and 8.7% 
attended a party. The most frequent activity reported (54.3% of participants) over the last seven 
days was attending (church) meetings.  
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4.6 Health services factors 
4.6.1 Perceptions of Quality of Health Care 
Almost all participants (98.9%) indicated that health care providers treated them with respect 
(Table 5). The majority (87.5%) of the participants reported that they were given the chance to 
 
 
Table 4: Social capital indicators 
                                                                  TOTAL                 Female             Male                 
Fear of discrimination by:  
Friends                                                       43 (23.4%)              37(28.2%)       6(11.3%) 
Partners                                                      12 (6.6%)                12(9.2%)              -  
Family                                                        25 (13.6%)              22(16.8%)       3(5.7%)                                     
 
Financial support                                         
Family support                                          36 (19.6%)                    28(21.4%)      8(15.1%) 
Unemployment grant                                 154 (83.7%)                  1(0.8%)          0(0%) 
Social grants                                              127 (69%)                   95(72.5%)         32(60.4%) 
Child grants                                                 56 (30.4%)                 54(41.2%)          2(3.8%)  
 
Social support 
Attend a support group                             48 (26.1%)                     34(26%)       14(26.4%)                    
 
Social activities over the past 7 days 
Took part in leisure activities                    21 (11.4%)                      7(5.3%)       14(26.4%)           
Visited bars                                                   14 (7.6%)                      3(2.3%)      11(20.8%)          
Attend meetings                                          100 (54.3%)                    75(57.3%)    25(47.2%)               
Visited friends/family members                   66 (35.9%)                   47(35.9%)     19(35.8%)           
Received visitors                                         75 (40.8%)                      55(42%)       20(37.7%)           
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state their problems and ask questions (Table 5). Almost all the participants (99.5%) reported that 
they trusted their health care providers and had excellent relations with them. About 96.2% 
(177/184) of the participants reported that in the ART facility they were treated in privacy and 
with confidentiality while 3.8% (7/184) indicated that were not treated in privacy during 
consultation and counselling (Table 5).  
Table 5: Health services factors 
 
 
4.6.2 Accessibility of services 
Access to the health facility was reported to be a problem for a small proportion (22.3%) of 
participants. A third of respondents (32.3%) indicated that it takes a lot of time and effort to 
 TOTAL Female Male 
Experienced problems travelling to hospital        41 (22.3%)       26(19.8%)              15(28.3%)           
Able to attend hospital during service hours 180 (97.8%) 128(97.7%)       52(98.1%)    
Chance to state problem and ask questions 161 (87.5%) 111(84.7%) 50(94.3%) 
Difficult to get extra ART if they finished   18 (9.8%)                                        16(2.2%)                     2(3.8%)                 
Privacy during consultation and counselling    7 (3.8%)                      5(3.8%)              2(3.8%) 
Takes lot of effort and time to get ART           62 (33.7%)                45(34.4%)         17(32.1%)    
Treated with respect by health care 
providers                                         
   2 (1.1%)                  2(1.5%)  
Trust health workers with their duties                 1 (0.5%)                    1 (0.8%)  
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receive their ART on the collection day. Almost 97.8% (180/184) participants reported that they 
were able to attend the hospital during the service hours, although more than half (52.2%) 
travelled more than 10 kilometres to get to the hospital. Thirty-five (19%) participants cited 
travelling more than 30 kilometres to the hospital (Figure 7). 
 
Figure 7: Distance to hospital (N=184) 
 
4.6.3 Waiting times in the ART site 
A major concern that was raised by the participants was the lengthy waiting times to receive their 
hospital file in the outpatient department.  The median waiting time in the Wellness clinic at the 
hospital participants spent was 32.5 minutes and IQR was 10 to 60 minutes (Figure 8). The 
median time they spent at the hospital was 3 hours (IQR: 2 - 4 hours) (Figure 9).  
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Figure 8: Waiting time for services  
 
Figure 9: Time spent during the last visit for reassessment and ART collection 
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4.7 Factors associated with adherence behaviour 
The ensuing section is organised to present two by two tables for socio-demographics and 
adherence, association between adherence and knowledge about antiretroviral therapy, 
association between knowledge and beliefs about antiretroviral therapy, association between 
adherence and social capital and association between adherence and health services factors. 
Furthermore, this section presents the two by two tables in self-reported adherence two day recall 
and seven day recall respectively. 
4.7.1 Socio-demographic characteristics and Adherence 
Self-reported adherence based on two day and seven day recall were not significantly associated 
with age, gender, employment status, marital status and education level (Table 6). 
 Table 6: Socio-demographic characteristics and Adherence  
 
 
 
 
 
 
 
 
 
 
 
 Adherence 
 
 Two day recall Seven day recall 
 χ² p-value χ² p-value 
Age 0.833 0.36 0.006 0.93 
Gender 0.402 0.52 0.083 0.77 
Employment status 0.292 0.58 3.211 0.07 
Marital status 2,209 0.53 1.655 0.64 
Education level 2.297 0.51 1.552 0.67 
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4.7.2 Side –effects and Adherence 
There was no association between participants reporting having experienced side effects and 
adherence based on two day (χ² = 0.349; p=0.55) or seven day recall (χ² = 1.588; p=0.20) (Table 
7). However, there was an association observed between females who experienced  side effects 
and ART adherence based on seven-day recall (χ² = 4.6197; p=0.03) (Table 7). Female patients 
who experienced side-effects after initiating antiretroviral therapy, were almost 3 times less 
likely (95% CI: 1.0682 – 7.4849) to have optimal adherence than those who did not report side 
effects. 
Table 7: Self-reported adherence and side effects  
 
 
 
 
 
 
 
4.7.3 Knowledge about ART and Adherence 
There were no statistically significant associations found between knowledge about ART and 
adherence on the two day and seven day recall (χ² = 0.44; p=0.50 and χ² = 0.77; p=0.37) (Table 
8). The individual responses to the knowledge and beliefs about ART questions were not 
 Adherence 
 
 Two day recall Seven day recall 
 χ² p-value χ² p-value 
Experienced side 
effects 
0.349 0.55 1.588 0.20 
           Female 0.036 0.84 4.6197 0.03* 
           Male 1.034 0.30 1.0542 0.30 
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meaningful in distinguishing reported adherence behaviour, with one exception. There was a 
statistically significant association found between participants knowing that “missing doses of 
ART leads to disease progression”, and ART adherence on two day recall (χ² = 12.2092; p=0.00) 
and seven day recall (χ² = 5.3740; p=0.02). Participants who knew that missing doses of ART 
leads to disease progression were 14 times less likely (95% CI: 8.33-23.77) and 7 times less 
likely (95% CI: 4.65-9.19) to have optimal adherence over the past two days and 7 days, 
respectively, than participants who did not know this.  
Table 8: Knowledge and beliefs about ART and adherence  
 
 
 
 
 
 
 
 
 
 
 
 Adherence 
 
 Two day recall Seven day recall 
 χ² p-value χ² p-value 
Knowledgeable about ART 0.4490 0.50 0.7777 0.37 
ART prevent to mother to 
child transmission      
0.01 0.91 0.44 0.50 
ART control HIV  0.33 0.56 0.26 0.60 
HIV can be cured by ART 0.05 0.82 0.19 0.65 
Taking ART prevent 
disease progression 
0.25 0.61 0.57 0.45 
Antiretroviral medicine can 
cause side effects 
1.15 0.28 0.00 0.96 
Missing doses of ART 
leads to disease progression 
12.209 0.00* 5.374 0.02* 
Missing doses of ART 
increases the risk of HIV 
transmission 
0.72 0.39 1.44 0.23 
Believe that ART is 
harmful to your body 
0.74 0.39 2.07 0.14 
 
 
 
 
 62 
 
 
4.7.4 Disclosure and Adherence 
There was a significant association between disclosure of HIV status and ART adherence (two 
day recall: χ²= 5.83; p=0.01). The point of estimation was undefined (Table 9).  However, this 
difference was not observed when considering adherence based on the seven day recall (χ²= 0.00; 
p=0.95).  
Significantly more participants who disclosed being on ART (167/179 = 98.2%) reported optimal 
adherence over the previous two days (χ² = 7.67; p = 0.00) and seven days (χ² = 7.576; p = 0.00) 
compared to those who did not disclose being on ART.   
Table 9: Disclosure and adherence  
 
 
 
 
 
 
4.7.5 Social capital and Adherence 
 
An association was observed in participants who attended support group and ART adherence 
than participants who did not attend support group (two days recall: χ² = 5.34; p = 0.02). The 
point of estimation was undefined in output of the results.  Attending a support group was not a 
discriminator of adherence levels (seven days recall: χ² = 0.43; p = 0.50) (Table 10). 
 Adherence 
 
Disclosure Two day recall Seven day recall 
 χ² p-value χ² p-value 
HIV status 5.83 0.01* 0.00 0.95 
 Being on ART 7.67 0.00* 7.57 0.00* 
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There was no association observed between adherence based on 2-day and 7-day recall and fear 
of discrimination by friends (χ²= 0.03; p=0.85; χ²= 0.13; p=0.71), family (χ² = 0.79; p = 0.37; χ²= 
0.30; p=0.57) or partner (χ² = 0.00; p = 0.92; χ²= 2.41; p=0.11), respectively, if ART status is 
disclosed (Table 10). 
Table 10: Social capital and adherence to antiretroviral therapy 
 
 
 
 
 
 
 
 
4.7.6 Barriers to adherence 
Leisure activities 
There was no association detected between adherence based on 2-day and 7-day recall took part 
in leisure activities and adherence (χ²= 1.50; p=0.22) and (χ² = 2.93; p= 0.08) respectively. 
However, female participants who took part in leisure activities were 75% less likely (95% CI: 
0.0672-0.9601) and 69% less likely (95% CI: 0.1222 – 0.8377) to have optimal adherence over 
two and seven days, respectively, than participants who did not take part in leisure activities. 
 Adherence 
 
 Two day recall Seven day recall 
 χ² p-value χ² p-value 
Support groups 5.34 0.02* 0.43 0.50 
Fear of discrimination by 
family 
0.79 0.37 0.30 0.57 
Worried about 
friends 
0.03 0.85 0.13 0.71 
Worried about 
partner 
0.00 0.92 2.48 0.12 
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There was a statistically significant association found between female participants who took part 
in leisure activities and ART adherence on two day recall (χ² = 3.91; p=0.04) and seven day 
recall (χ² = 4.35; p=0.03) (Table 11).  
 
Attending Party 
There was no association found between attending a party and ART adherence (two day recall: 
χ²= 1.44; p= 0.22; seven day recall: χ²= 1.1267; p=0.28).  
 
Attending meetings 
Participants who attended meetings were 61% less likely (95% CI: 0.1654–0.9481) to have 
optimal adherence over the past seven days than participants who did not attend meeting (χ²= 
4.5286; p= 0.03) (Table 14). However, this association was not observed with reported adherence 
based on two day recall (χ²= 0.8064; p = 0.36). Female respondents, who attended meetings were 
4 times less likely (95% CI: 1.01 – 15.84) to have optimal adherence over the previous two days 
than females who did not attend meetings. Therefore, a significant association was observed 
between female participants who attended meetings and ART adherence (χ²= 4.4098; p = 0.03). 
 
Eating at a restaurant 
There was no correlation observed between eating at a restaurant and ART adherence based on 
two day recall (χ²= 0.21; p=0.64) and on seven day recall (χ²= 1.44; p=0.22) respectively. 
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Received visitors 
There was an association between received visitors and ART adherence based on 2-day and 7-
day recall (χ²= 7.09; p=0.00) and (χ² = 5.74; p= 0.01) respectively. Participants who received 
visit from friends or family were 10 times less likely (95% CI: 1.20 - 66.93) and 2 times less 
likely (95% CI: 1.13 – 6.17) over two and seven days, respectively, to have optimal adherence 
than those did not receive visit.   
 
Visited friends 
There was no association detected between adherence based on 2-day and 7-day recall   and 
visited friends (χ²= 0.35; p=0.55) and (χ² = 0.45; p= 0.50) respectively. 
 
Visited a bar 
Participants who visited a bar were 61% less likely (95% CI: 0.18 – 0.88) to have optimal 
adherence than those did not visit a bar. This was found to be associated with adherence 
behaviour (χ²= 4.5440; p=0.03) on the seven day self report. However, there was no association 
observed between visited a bar and ART adherence on the two day self report. 
 
Forgetful 
A significant association was observed between forgetfulness and ART adherence over the 
previous two days (χ² = 8.91; p= 0.00) and seven days (χ² = 69.33; p = 0.00). Participants who 
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reported forgetfulness were 76% less likely (95% CI: 0.09-0.65) and 92% less likely (95% CI: 
0.04 – 0.17) to have optimal adherence over two and seven days, respectively, than participants 
who did not report forgetfulness to be a barrier. There was no association observed between 
female participants who forgot to take their doses of ART and adherence based on the two day 
recall (χ²= 2.61; p= 0.10). However, a significant association was observed between female 
participants who forget to take their doses of ART and adherence (χ²= 42.12; p= 0.00).  Based on 
seven-day recall participants who forgot to take their doses of ART and adherence were 96% less 
likely (95% CI: 0.01 – 0.13) to have optimal adherence than those who did not forget to take 
their doses of ART (Table 11).   
 
Sleep away from home 
Participants who slept away from home were 76% less likely (95% CI: 0.13 – 0.45) to have 
optimal adherence than participants who did not sleep away from home. This was found to be 
statistically significant (χ²= 20.29; p = 0.00) over seven day recall. However, there was no 
association was observed on the two day recall (χ²= 1.0247; p=0.31) between sleep away from 
home and ART adherence.  
 
Daily routine 
It was observed that there was a significant correlation between daily routine and ART adherence 
(χ²= 16.30; p=0.00) on seven day recall. Participants who cited that their daily routine was a 
barrier affected them in taking medication at specific times were 86% less likely (95% CI: 
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0.1006 – 0.2050) to have optimal adherence than participants who cited that daily routine was not 
barriers for taking medication. However, no association was observed between daily routine and 
ART adherence over two day recall (χ²= 2.87; p=0.90) (Table 11).  
Table 11: Barriers to adherence 
 Two day recall Seven day recall 
 χ² p-value χ² p-value 
Attend meetings  0.80 0.36 4.529  0.03* 
          Female (n= 75) 4.40 0.03* 1.567 0.21 
Took part in leisure 1.50 0.22 2.93 0.08 
      Female 3.91 0.04* 4.35 0.03* 
Attend a party 1.44 0.22 1.12 0.28 
Eating at a restaurant 0.21 0.64 1.44 0.22 
Received visitors 7.09 0.00* 5.74 0.01* 
Visit friends 0.35 0.55 0.45 0.50 
Visited a bar 0.00 0.94 4.54 0.03* 
Forgetful 8.91 0.00* 69.33 0.00* 
Female 2.61  0.10 42.12 0.00* 
Sleeping away from home 1.02 0.31 20.29 0.00* 
Daily routine 2.87 0.90 16.30 0.00* 
 
4.7.7 Health services factors  
There were no statistically significant associations found between lost or ran out of ART and 
adherence based on the two day and seven day recall (χ²= 0.348; p=0.55 and χ²= 2.1701; p=0.14) 
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(Table 12). Furthermore, there was no association was observed between privacy during 
consultation and counselling and ART adherence (two day recall: χ²= 0.461; p=0.49) and (seven 
day recall: χ²= 0.012; p=0.91). There was a significant association observed between privacy 
during consultation and counselling and adherence (two day recall: χ²= 8.975; p=0.00). However, 
privacy during consultation and counselling was not a barrier to ART adherence levels based on 
seven day recall (χ²= 2.7068; p=0.09).  
Based on two day and seven day recall, there was  no significant association detected in: takes lot 
of time and effort to receive ART (χ²= 1.021; p=0.31; χ²= 0.1009; p=0.74),  given the chance to 
state problems and ask questions (χ²= 0.044; p=0.83; χ²= 0.988; p=0.32) , attend hospital services 
during set time (χ²= 0.337; p=0.56; χ²= 0.263; p=0.67), treated with respect by the health care 
providers (χ²= 0.167; p=0.68; χ²= 0.378; p=0.53) respectively.  
Participants who trusted health care provider were 14 times less likely (95% CI: 8.3361 – 
23.7713) to have adherence than those who did not trust health care providers in two day recall. 
Therefore, there was an association between trust health care providers and ART adherence (χ² = 
12.209; p = 0.000). Nevertheless, there was no association was observed between trust health 
care providers and ART adherence based on seven day recall (χ²= 0.1881; p=0.66).   
Participants who had problems with travelling to hospital in two day recall were 75% less likely 
(95% CI: 0.082 – 0.761) to have optimal adherence than those indicated that they do not have 
problem with travelling to hospital. In other words, there was an association between problems 
travelling to hospital and ART adherence (χ²= 0.722; p=0.01). However, there was no significant 
association between experiencing problems travelling to hospital and adherence based on seven 
day recall (χ²= 2.959, p=0.08).  
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Table 12: Health services factors and adherence  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Hours spent during previous review were observed to be associated with adherence based on 
seven day recall (p < 0.05). However, there was no relationship between waiting time at health 
service and adherence was observed on both two day and seven day recall (Table 13).  
 
 Adherence 
 
 
 
Two day recall Seven day recall 
Barrier χ² p-value χ² p-value 
Lost/ran out of ART 0.348 0.55 2.1701 0.14 
Privacy during consultation 
and counselling 
0.461 0.49 0.012 0.91 
Privacy during consultation 
and counselling (Male 
unemployed) 
8.975 0.00* 2.7068 0.09 
Lot of time and effort  1.021 0.31 0.109 0.74 
Attend hospital services 
during set time 
0.337 0.56 0.263 0.60 
Trust health care providers 12.209 0.00* 0.1881 0.66 
Chance to state problem 
and ask questions 
0.044 0.83 0.988 0.32 
Treated with respect 0.167 0.68 0.378 0.53 
Travelling problem to 
hospital 
6.722 0.01* 2.959 0.08 
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Table 13: Waiting and service times and Adherence 
 
 Adherence 
 
 Two Days Recall Seven Days Recall 
 t-test P-value t-test P-value 
Time spent during past visit to 
health service 
0,240 0,810 1,968 0,050 
Waiting time at health service 1,797 0,074 1,436 0,152 
 
 
4.8 Summary  
The results of this study show that more females than males participated in the study. More than 
half of the participants were single. All participants managed to name the regimen and describe 
the correct methods of taking ART. Most of the participants in this study were knowledgeable 
about ART and indicated that ART is effective and improves quality of life. Interestingly, self-
reported adherence based on two day recall was more than seven day recall. The three leading 
barriers to adherence were problems with travelling to hospital, forgetfulness, and sleeping away 
from home. Majority of the participants in this study disclosed HIV status and being on ART. 
However, there were participants who feared discrimination but this was not associated with 
adherence. 
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CHAPTER FIVE 
DISCUSSION  
 
In this section, the discussion attempts to explain and interpret the current study findings and 
compare them to the results found in similar studies. Therefore, discussion of the results will 
follow the following sub-groups: description of study participants, participants’ information 
about antiretroviral therapy, perceptions and beliefs about ART, adherence assessment, social 
support, coping skills and health services factors as well as factors associated with adherence. 
Lastly, this section will also acknowledge the limitations of the study.  
 
5.1 Description of study participants 
A total of 184 participants participated in the study and were selected using a sample random 
sampling method. The participants were on ART for at least 6 months and were between the ages 
of 15 – 65 years. The data were collected from the participants using a structured questionnaire.        
5.1.1 Age  
The mean age of participants on ART is fairly low 38.9 years. This confirms the high prevalence 
of HIV among adolescents and middle adulthood from the age group of 15 – 65 years. This 
could be due to that within this age group; human beings have a marked tendency to engage in 
sexual activities and in high risk behaviours which results in contracting HIV infection. These 
age groups were selected because Department of Health in South Africa (2007) and WHO 
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(2006) illustrated that in this age group more people are more likely to be HIV infected. This 
study also indicated that more than half of the participants 54% had achieved at a secondary 
level of education, showing a high level of literacy. Nevertheless, age was found to be not 
associated with adherence to antiretroviral therapy. Although studies by Mehta, Moore and 
Graham (1997), Gordillo, del Amo, Soriano and González,-Lahoz (1999), Chesney (2000) have 
identified that younger individuals struggle to comply with treatment because of dependence to 
their caregivers to administer their medication. 
 
5.1.2 Gender 
The study comprised of 72% female participants and 28% male participants. The finding is also 
consistent with another study which found that women are more likely to be vulnerable to HIV 
infection than men (WHO, 2006) and interestingly, they also tend to use health services facilities 
as shown by this study. This suggest that there is a need of a study to find out about the 
perception of men about visiting wellness clinic for voluntary counselling and testing. However, 
gender was not associated with adherence to antiretroviral therapy between the two day and 
seven day self-report. 
 
5.1.3 Employment status 
A unique finding from this study is that 83.7% of the participants were unemployed. This could 
be explained by the fact that Nkomazi region is rural and employment opportunities are scarce. 
Sixty-nine percent of the participants in the present study indicated that they were receiving 
disability grant, and some of the female participants (30.4%) also receive child grants. This is in 
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line with a studies done by Booysen (2004) and Louwagie, Bachmann, Meyer, Booysen, Fairall 
and Heunis (2007) that found that most of the households in South Africa depended on the social 
and child grants that are provided by the government. In addition, this issue of financial 
constrains is supported by Mills et al. (2006a) and the National Department of Health (2007) 
which cited that severity of the HIV epidemic is closely linked to poverty and other socio-
economic factors. This finding was expected because most of PLWHA are likely to struggle with 
finances. In addition, this is supported by UNAIDS (2006) who found that people in productive 
age are badly affected by HIV and they also unable to meet their basic needs such as food, health 
care, and shelter. These difficulties are also experience by their children who end up being 
orphans as their parents passed away due illness related to HIV/AIDS. Hence, it can be 
suggested that a future research which can investigates the impact of poor economic status in 
patients receiving ART in rural areas. However, employment status was not significantly 
associated with adherence to antiretroviral therapy.  
 
5.2 Knowledge about antiretroviral therapy  
5.2.1 ART regimen 
Patients’ knowledge has previously been cited to be closely associated with adherence to ART 
(Mehta, Moore and Graham, 1997). The result of this study indicated that majority of the 
participants were able to report about the doses of their ART. Ten percent of those participants 
who reported that they did not attend school were able to identify their medication in different 
containers. Although, these results differ from some published studies which indicated that low 
level of education was associated with poor adherence and may impact negatively on some 
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patient’s ability to adhere (Gordillo et al., 1999; Kalichman, Ramachandran and Catz, 1999; 
Heath, Singer, O’Shaughnessy, Montaner and Hogg, 2002; Pinherio et al., 2002; Reynolds et al., 
2004; Hofer, Schechter and Harrison, 2004; Kagee, Le Roux and Dick, 2007; Falagas, 
Zarkadoulia, Pliatsika and Panos, 2008).  
A small proportion of patients reported missing pills over the past two days and seven days 
(Table 4). The most frequently cited barriers were problem with travelling, forgetting to take 
ART, sleeping away from home, and the daily routine/work (Table 6). This finding confirms 
what is well established from the literature that forgetfulness and being away from home affect 
adherence to antiretroviral therapy negatively (Roberts, 2000; Reynolds et al., 2004; Marais, 
2006; WHO, 2006; Dieckhaus and Odesina, 2007; Wang and Wu, 2007; Thobias, 2008; 
Malangu, 2008). 
 
5.2.2 Side-effects 
In this study, one hundred and thirty-two participants cited that they did experience side-effects 
in their lives after initiating ART. It is possible, therefore, that the statistical significance found 
in seven-day recall between side-effects and adherence to ART, might be explained by the fact 
that the experience of side effects did not influence the participants from taking their medication. 
However, the findings of the present study do not support the past research.  Side-effects have 
been identified in various studies as significant barriers to optimal adherence (Gordillo et al., 
1999; Roberts, 2000; Heath et al., 2002; Remien et al., 2003; Marias, 2006). The authors found 
that side-effects have a negative impact on adherence to ART, activities of daily living and 
quality of life. 
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5.3 Knowledge and beliefs about antiretroviral therapy 
The findings of this study show that patients on ART were excessively positive and confident on 
the questions of attitudes and beliefs about ART. Of the participants (98%) accepted that taking 
ART prevents disease progression; (100%) ART is effective and prolongs life, (100%) not 
starting ART when indicated can make them sick, (100%) ART improves quality of life and 
(99%) missing doses of ART leads to disease progression also (96%) increase the risk of 
transmitting HIV. A possible explanation for this might be that these participants were fully 
involved in their adherence education and consistently attend adherence counselling. Another 
explanation for this might be that participants already experienced the benefit of ART. This 
study produced results which corroborated with the findings of a great deal of the previous work 
in this field. Studies by Chesney (2000),  WHO (2002, 2006), Gebo (2003), Coetzee et al. 
(2004), Hofer (2004),  Moore et al. (2005), Dickhaus and Odesina (2007) have shown that 
participants are more likely to receive benefits when they adhere to their antiretroviral 
medication.   
The most interesting finding was that 100% of the participants cited that they do not believe that 
traditional medicine is more effective than prescribed medication. Furthermore, this result could 
be explain by that patients tried to use traditional medicine prior to initiating ART but realized 
that traditional medicines were not working then they alternatively switched on to ART.  
The study found that other participants’ level of knowledge and beliefs about antiretroviral 
treatment was incorrect. Less than half of the participants (23%) mentioned that HIV can be 
cured by ART. The reason for this perception might be that participants of this study noticed that 
their quality of life has improved after they initiated ART. In addition, the current study found 
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that 53% of the participants believe that ART is harmful to their bodies while 47% did not 
believe that ART is harmful to their bodies.  
On the question of patients’ perceptions and attitudes believe that missing doses of ART leads to 
disease progression, this study found that this was associated with adherence to ART. The 
possible explanation is that participants had time to contemplate and take action to adhere to 
ART.  
 
5.4 Adherence assessment 
5.4.1 Self-report  
In this study, high proportion of patients who were receiving ART had optimal adherence to 
ART, by self-report in two and seven days recall as figure 3 indicates. The results of this study 
show that 92.4% of the patients on ART were having more than 95% adherence to ART in two-
day recall, whereas in seven-day recall 84.2% of the patients on ART were found to be having 
more than 95% adherence to ART. This is also in line with the study of Akpomiemie (2005) who 
also found that 92.4% of the population receiving ART having more than 95% adherence to their 
HIV medication. The higher percentages of adherence to ART support the work of Reynolds et 
al. (2004) that strong internal commitment to health related behaviour influences the ability of an 
individual to adhere to their medication. This also confirms the findings from past research on 
health belief model that show that when patients perceive benefits of ART are more likely to 
adhere to their medication (Reynolds et al., 2004). However, these data must be interpreted with 
caution because the tool used to measure adherence to ART has strengths and weaknesses. There 
are several possible explanations for this result. In two-day recall has the advantage that 
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participants were able to recall in a short time span, which suggests that memory of medicine 
intake is likely to be good. However, it can overestimate medicine intake because participants 
may feel ashamed to disclose to forgetting to take their medications so recently. It is difficult to 
explain the result of reduced adherence to ART in seven day recall, but it might be related to 
recalling information of long-term memory of the past seven days. These explanations are 
consistent with those of Fogarty et al. (2002), Wagner (2002), da Salviera et al. (2003), Roux 
(2004), Levine et al. (2006), Liu et al. (2006), Marias (2006), Simoni et al. (2006) and Dzinza 
(2007), declare that measuring adherence to ART is a difficult activity in both clinical and 
research setting. These authors point that there is a controversy regarding the reliability of 
current methods used to measure adherence to antiretroviral therapy.    
 
5.4.2 Barriers to adherence to antiretroviral therapy 
The study found that there were barriers to adherence to antiretroviral medication among the 
participants. Small proportion (15.8%) of participants reported experiencing barriers to follow 
the ART regimen. With regard to barriers for missing doses, the findings of this study indicated 
that travelling, forgetting to take ART medication, sleeping away from home, and the daily 
routine/work were most common. These findings concurred with other research. Patient 
forgetfulness cited as a barrier to ART adherence (Roberts, 2000; Reynolds et al., 2004; Marais, 
2006; WHO, 2006; Dieckhaus and Odesina, 2007; Wang and Wu, 2007; Thobias, 2008; 
Malangu, 2008).  These authors mentioned that patients on ART simply forget to take treatments 
due to being away from home attending social events such as night vigil, funerals, weddings and 
parties.  
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5.5 Social capital 
5.5.1 Disclosing HIV status and antiretroviral therapy 
It is interesting to note that the vast majority of the participants cited that they have disclosed 
their HIV status to various people such as siblings, grandparents, aunt/uncle, partner and other as 
presented in figure 5. Less half than half (42.5%) participants disclosed their HIV status to their 
partners. This might be a challenge for the participants who did not disclose HIV status to their 
partners because they experience difficulties to use their medication. It is difficult to explain this 
result, but it might be that persons with HIV infection are realizing that secrecy would not help 
them. The present findings seem to be consistent with other research which found that disclosing 
HIV status result in support from family members and significant others and is a strong indicator 
of medical adherence (Chesney et al., 2000; Bearman and La Greca, 2002; Simoni, Frick, 
Lochkart and Liebovitz, 2002; Attawell and Mundy, 2003; Hofer, Schechter and Harrison, 2004; 
Mills et al., 2006b; Kagee, Le Roux and Dick, 2007). This is also in line with the work of Dunn, 
McClain, Brown and Youngstrom (1998) which emphasized that human performance is the 
interaction between a person and environment which affects human behaviour and task 
performance. Moreover, the majority of participants who disclosed their HIV status indicated 
that they were not worried that loved ones and significant people would find out about their HIV 
status. This may be explained by the fact that these participants are excessively positive and 
motivated about their medication. It can thus be suggested that openness about the HIV status 
and taking ART provide the participants with the support and adhere to their medication without 
fear.  
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In this study, however, it was found that there were participants who cited that they did not 
disclose their HIV status to anyone. In addition, six percent of the participants who participated 
in the study were concerned about the reactions of their sexual partners and family members if 
find out that they were HIV infected. This finding may be explained by the fact that people with 
HIV infection are likely to experience rejection and discrimination in their families and 
communities as well as fear of their partners’ reactions as some literature has demonstrated that 
disclosing HIV status is a “double edge sword” as it builds or breaks up a person motivation 
(Van Dyk, 2001; Timmons and Lynch, 2004). The present findings seem to be consistent with 
other research which found that people living with HIV and AIDS receive positive support from 
their loved ones, other are discriminated against, rejected and isolated from their families.  
The findings of this study show that 97% of the participants disclosed being on ART as 
illustrated (Figure 6). A possible explanation for this might be that participants are fully aware 
and educated that it is important to inform someone about taking ART medication for support. In 
the findings of the study, 2% of participants did not tell anyone about using ART.   This 
confirms the findings of Qwana et al. (2000) and Nachega et al. (2005) who cited that patients 
who did not divulge information about taking ART medication were concerned about rejection 
by sexual partners, family members, friend and community members. The authors also reported 
that rejection has a devastating impact on participants when they are expected to comply with 
their ART medication. These findings suggest that unsafe sexual activities and HIV transmission 
would continue to be a problem if the participants are still not accepted by their partners.  
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5.5.2 Support groups 
The findings of the study indicated that there were participants who participate in support groups 
in the community where they live. The findings are confirmed by those of Attawell and Mundy 
(2003) who found that buddy support and support groups play an important role for participants 
in order to adhere to their medication. However, there is a need for further research to be 
conducted, in order to develop a better understanding of the role of support groups in the life of 
the participants on ART. 
 
5.5.3 Traditional medicine and prayers 
The findings of this study revealed that all the participants (100%) they did not believed that 
traditional medicine is more effective than ART. However, the findings of the current study do 
not support the previous research by Van Dyk (2001) and Aidsguide (2006) cited in (Marais, 
2006) cited that participants have a tendency to mix different forms of treatment including faith 
based healing, alternatives and conventional and traditional medicine.  
In this study, participants reported that they do attend church, therefore, it was found to be 
associated with adherence. This is supported by other prior studies who reported that some of the 
women used prayers as a coping skill because of the belief that they might be healed from the 
disease (Bader et al., 2006; Thobias, 2008). A similar trend was also reported by Dzinza (2007) 
who found that physicians in Botswana were concerned about the information spiritual leaders 
gave their participants such as advising to stop taking ART as they would pray for them and cure 
the disease.  
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5.5.4 Social events 
The results of this study have shown that 11% of the participants were mixing with other people 
in the community when they go out for leisure activities such as watching soccer in the local 
sport ground. A possible explanation for this might be that these participants benefited from 
watching the soccer to relieve their personal stresses.  
 
5.6 Health services 
5.6.1 Perceptions of Quality of Health Care 
The improvement in the quality of care of patients’ life and motivation for adhering to ART 
medication is influenced by the behaviour of both participants and health care provider. 
Therefore, in this study it was found that the relationship between patient and health care 
provider is associated with adherence to ART. A possible explanation for this might be that the 
participants had trust on their health care providers and had excellent relationship with them. 
Another possible explanation for this is that participants in the study site were treated with 
respect by the health care providers. There are, however, other possible explanations such as 
participants were treated with privacy and confidentiality during consultation and counselling by 
the health care providers. The findings also support Chesney (2000), Marias (2006) and WHO 
(2006) that the relationship between patient and health care provider predicts the success and 
failure of ART in the improvement of quality life. Furthermore, these findings are consistent 
with other studies and suggest that participants are supposed to be active members in decision-
making during discussion of ART medication options and information exchange (Barker et al., 
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2004; Bader et al., 2006). This is also supported by Prochaska (2008) who also cited that 
decision making is an integral part of behaviour change. 
This study has not been able to demonstrate that participants were ill-treated by the health care 
providers as Remien et al. (2003) found that participants were inhumanely treated such as being 
called names, like “cattle or number” and “guinea pigs”.   
 
5.6.2 Accessibility of services 
The findings showed that 77% of the participants were able to come to the hospital during 
services hours and set dates. This result may be explained by the fact that 87.5% of the 
participants cited that they were given opportunity to state their problems and ask questions 
during consultation on the day of follow-up with the health care providers. It is hypothesized that 
when participants are involved in decision making for follow-up appointments probability of 
respecting their appointments are high. This hypothesis is confirmed by the findings of the study, 
it became apparent that ability and willingness of health care providers to involve the 
participants resulted in positive impact on participants.  Therefore, the findings of the current 
study support previous research by Thobias (2008) who found that appointment dates were often 
a challenge to adhere to for participants in Namibia as they were not involved in decision-
making of follow-up dates. This is also supported by Pinheiro et al. (2002), Attawell and Mundy 
(2003), Marias (2006) who found that financial resources to travel to the health facilities were 
problematic resulting in participants missing their follow-up appointments. It can also therefore 
be assumed that the lack of financial resources would make participants to miss their 
appointment dates.  
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From the findings of this study figure 7 indicated that some participants who travelled a distance 
of more than 30KM to the hospital in order to receive their ART medication. The present 
findings seem to be consistent with the study conducted by Wieser et al. (2003) and WHO 
(2006) who found that participants travelled a distance of 800 to 1000KM.  
From the findings of this study, there was a significant association between problems with 
travelling to hospital and adherence to ART. Given that some of the prior literature has 
consistently demonstrated that cost for transport to travel to health facility is often a challenge 
for participants (Jaffar et al., 2005; Popa-Lissenanu et al., 2005).  
 
5.6.3 Waiting times  
From the findings, figure 8 and 9 indicated that some of the participants spend long hours as well 
as minutes in the hospital on the follow-up day. The participants had at least one complaint 
against the outpatient department (OPD) that they waste lot of time waiting to receive their 
hospital files. These findings are consistent with those of WHO (2006) who found that long time 
waiting is a major challenge to adherence among ART participants in Botswana, Tanzania and 
Uganda. In addition, WHO indicated that prolonged waiting times have negative effect to 
follow-up appointments and adherence. On that note WHO recommended that health facilities 
should avoid long waiting of participants to consultation and medication in order to maintain 
high adherence levels over long period.  
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5.7 Factors associated with adherence to ART 
Various factors associated with adherence to ART in the present study were identified during 
self-report in two days recall and seven days recall.  
5.7.1 Disclosing HIV status and antiretroviral therapy 
Ninety-seven percent of the participants disclosed their HIV status to their loved ones. This 
factor was identified as having a potential association with adherence to ART. This could be 
explained by the fact that there were participants who believed that antiretroviral medicine 
improves the quality of life. This also could be linked with the fact that some of the participants 
were not concerned about the reactions of their families, friends and partners.  
 
5.7.2 Daily routine/work  
Daily routine work was associated with adherence to ART. Although the reason for this 
association is unknown, possibilities include that carrying medication to work made it for one to 
remember to take medication when others are also doing the same. Forgetting taking medication 
however, could have a negative impact to their health.   
 
5.7.3 Missing doses of ART leads to disease progression 
Participants’ believed that missing doses of ART leads to disease progression and was associated 
with adherence to ART. The reasons for this are not clear but it may have something to do with 
informational support about ART and could be that participants were aware that ART decrease 
morbidity and mortality. 
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5.7.4 Problems with travelling to hospital 
Having problems coming to hospital had statistical significance with adherence to ART. It seems 
this is due to economic problems. This finding is in line with Mills et al. (2006a) who found that 
daily schedules were barriers to ART adherence during the systemic review. 
 
5.7.5 Trust health care providers 
Participants’ trust on health care providers was strongly associated with adherence to ART. This 
could be explained by several possible reasons that will be discussed in health services 
specifically in quality of care. 
 
5.7.6 Visiting bar 
Visiting bar was found to be connected with adherence to ART. This finding is in line with other 
studies that found that active alcohol consumption and drug abuse result in forgetfulness to take 
ART medication and increase probabilities of engaging in health risk behaviours (Golin et al., 
2002; WHO, 2006; Mills et al., 2006b).  
 
5.7.7 Sleep away from home and patient forgetfulness 
With regard to reasons cited for missing doses, the findings from this study concur with reports 
from literature that sleeping away from home and patient forgetfulness both were found to be 
strongly associated with adherence to ART. This is consistent with the studies of Mehta, Moore 
and Graham (1997), Roberts (2000), Reynolds et al. (2004), Marais (2006), Mills et al. (2006a), 
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WHO (2006), Dieckhaus and Odesina (2007), Wang and Wu (2007), Malangu (2008) and 
Thobias (2008) who found that forgetting to take medication due to social events such as funeral, 
night vigil, parties and weddings was a barrier to adherence to ART.  
 
5.7.8 Attending meetings and receive visit from friends or family members 
Attending meetings/church and receive visit from friends or family members both factors were 
associated with adherence to ART. This could be explained by the fact that participants had 
opportunity to share their knowledge with other people in the community.  
Total ART missed, hours spend past visit and total times missed in taking ART were found to be 
associated with adherence to ART.  
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5.8 Limitations of the study 
There are several limitations to the present study that may affect the validity and generalizability 
of the results. Therefore, the findings of this study must be interpreted in the light of its 
limitations.  The following limitations are relevant: 
 The study was conducted at a single site at Ehlanzeni district, Nkomazi region which roll-out 
ART and did not cover other health facilities rolling-out ART. Therefore, the findings of this 
study may not be generalized to other health facilities delivering ART services because of small 
sample size.  
 The study used self-report for measuring adherence to ART in two days and seven days. 
However, this method of measuring adherence is known to overestimate and recall bias.  
 The study planned to measure adherence to ART with viral load and CD4 cell counts 
however, due to time constraints and cost, the biological assays could have provided more 
information on the adherence level to ART 
 This study used cross-sectional survey due to the nature of this design which is known to only 
provide prevalence ratio not causes. Therefore, it will be inappropriate to imply that factors 
found to be associated with adherence to ART are main causes.  
 This study did not include the health care providers who are receiving ART in the site. Their 
participation would be of help to describe their perception about the adherence behaviour.   
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5.9 Summary 
The discussion dealt with the major findings of the study. Similarities with other studies were 
found with regard to knowledge, attitude, belief and adherence behaviour of patients on ART. 
The limitations of the study have also been described. The summary of the study, conclusion and 
recommendations based on the findings will be presented in the next chapter. 
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CHAPTER SIX 
CONCLUSION AND RECOMMENDATIONS 
 
6.1 Conclusion 
In conclusion, participants’ adherence levels in Nkomazi region appear to be comparable with 
those in other regions in South Africa, despite the fact that participants in Nkomazi region faced 
financial constraints and high unemployment rates. The findings of this research can contribute to 
developing expertise around adherence to ART among patients before initiation of treatment and 
during treatment. This expertise can be used in the development of effective support groups. 
Furthermore, the research can be used for lobbying policies aimed at issuing two month’s supply 
of ART in order to promote adherence to ART. Lastly, it is hoped that the results and learning as 
well as recommendations from this study can be used by future researchers in the field to conduct 
research and improve on the current study. The study also revealed that there were patients who 
did not inform their sexual partners about their HIV status and taking of ART. These findings 
also suggest that people living with HIV and AIDS are still experiencing stigma in their families 
and communities. 
It was evident that the health services environment was conducive for patients receiving ART as 
it was indicated that they were treated with respect and all issues discussed were always kept 
confidential. Some of the patients on ART in this study indicated that there were several 
occasions on which they did not take their HIV medication either because they forgot or because 
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they were busy with their daily routine work. This was also common to patients receiving ART in 
different settings as discussed in the literature review.  
 
6.2 Recommendations 
Recommendations are grouped in 4 themes, relating to health care providers, comprehensive 
policy guideline to address adherence to ART, Community and Future Research. 
Health Care Providers 
o It emerged from this study that health care providers treat patients with care and empathy 
during consultation and counselling, therefore it is important that health care providers should 
assess and monitor challenges to ART adherence among the patients receiving ART. 
o The findings revealed that some of the patients had problems with travelling to hospital for 
ART. This may be the opportunity for health care providers to advocate for patients to be 
down referred to local clinics. 
o The findings shown that there was a significant association between forgetfulness and ART 
adherence over the previous two days and seven days. Therefore, health care providers should 
encourage patients to use reminders such as cell phones, family members and treatment 
buddies. 
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A comprehensive policy guideline to address adherence to ART 
o From the results, it was noted that majority of the patients were unemployed. Therefore, there 
is a need for strengthening intersectoral collaboration among different departments to enhance 
Integrated Development Plan (Department of Health, Department of Social Development, 
Department of Agriculture and Department of Labour). Furthermore, the intersectoral 
collaboration could assist in establishing income generating projects for people living with 
HIV and AIDS so that they can meet their financial needs that affect their well being.  
 
Community  
o The study noted that less than half of the patients participated in support groups in the 
community. Therefore, it is important to encourage patients to establish support groups in their 
communities in order to share knowledge, experiences and coping skills as they are using 
ART 
o From the study, it was observed that there were few male patients attending ART services. In 
response to this, it may be important to involve men in the issues of HIV and AIDS in order to 
reduce denial, rejection and stigma. 
Future Research 
o As the study was a cross sectional, therefore is a need to conduct a qualitative study to 
explore and describe patients’ perceptions about utilization of antiretroviral therapy.  
o Further research aimed at assessing men’s knowledge, attitudes, beliefs about HIV/AIDS and 
antiretroviral therapy in Nkomazi region. 
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Appendix 1: Approval from University of the Western Cape Higher Degrees Committee 
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Appendix 2: Mpumalanga Province Department of Health Research Ethics Approval  
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Appendix 3: Participant Information Sheet 
 
  UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
Tel: 021- 959 2809, Fax: 021- 959 2872        
PARTICIPANT INFORMATION SHEET 
Introduction: You are invited to take part in a research study entitled “Knowledge, attitudes, 
beliefs and adherence to antiretroviral therapy among People living with HIV/AIDS receiving 
treatment at Shongwe Hospital in Nkomazi region, Mpumalanga Province”. 
This consent form provides information about the research study. I will be available to answer 
your questions and provide further explanations. If you agree to take part in the research 
study, you will be asked to sign this consent form. This process is known as Informed 
consent. You are free to withdraw from participating in the study. The researcher is Thuli 
Mthembu. 
Purpose: As a student of University of the Western Cape (Cape Town, Republic of South 
Africa). I am conducting a research study to assess the factors associated with adherence 
including knowledge, attitudes and beliefs. Furthermore, this study will assists in promoting 
adherence among ART patients.  
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Eligibility:  Patients on antiretroviral therapy. 
Procedures:  
Possible risks: The data collected will not be utilized to cause you any form of harm.  
Possible benefits: You will not obtain any personal benefit from participating in this study. 
You will only be able to express your views and feelings, for the benefit of the patients on 
antiretroviral therapy. 
Costs: There are no costs to you for participating in this study. Only your time shall be 
requested.  
Privacy of research records: The interview will be private. Supervisor representing University 
of the Western Cape may review the data collected. If that happens, I will give them copies of 
the information that are only related to the study. These copies will not have any information 
that can link you to the study. The data derived from the questionnaires will be used for 
research purposes only and at the end of the study; all records will be destroyed and shred.  
Questions: If you have any questions about the study, please speak to Mr. T.G. Mthembu in 
person. Contact: 0723101503 
Signatures: By signing this consent form, you agree that you have read this (If) you 
understand what is involved; you agree to participate in this study. 
 
Signature………………………………………..Date………………………….. 
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Witness.………………………………………..Date………………………….. 
Appendix 4: CONSENT FORM 
 
Title of Research Project: Knowledge, attitudes, beliefs and adherence to antiretroviral 
therapy among People living with HIV/AIDS receiving treatment at Shongwe Hospital in 
Nkomazi region, Mpumalanga Province. 
The study has been described to me in language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered to my satisfaction. I 
understand that my identity will not be disclosed and that I may withdraw from the study 
without giving a reason at any time and this will not negatively affect me or the treatment 
that I receive at this facility in any way.   
 
 
Participant’s name……………………….. 
 
Participant’s signature……………………………….                                   
 
 
Date……………………… 
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Appendix 5: QUESTIONNAIRE 
I wish to learn about your Knowledge, attitudes, beliefs and adherence regarding ART. I hope to 
understand your needs and the best way to bring information to you, as well as barriers to 
seeking medical care. The information you provide will be used to improve ART. Your answers 
will not be released to anyone and will remain anonymous. Your name will not be written on 
the questionnaire or be kept in any other records. Participation is voluntary and you may choose 
to stop the interviews at anytime. 
Thank you for your assistance. 
SECTION A (DEMOGRAPHIC)  
1. How old are you? 
2. Gender of respondents 
Male  1 
Female 2 
 
3. What is your current marital status? 
Single 1 
Married 2 
Widowed 3 
Divorced 4 
 
4. What is your highest level of education obtained? 
No schooling 1 
Primary Schooling 2 
Secondary 3 
Post Secondary 4 
Tertiary 5 
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5. What is your employment status? 
Employed 1 
Unemployed 2 
  
6. What is your approximate monthly salary/income?  
R200 or less 1 
R300 – R500 2 
R600 – R700 3 
R800 – R1000 4 
    >R1000 5 
 
7. How far do you have to travel today to come to the 
hospital? 
0 – 10 Kilometers 1 
11 – 20 Kilometers 2 
21 - 30 Kilometers 3 
More than 30 Kilometers 4 
 
    
SECTION B SOCIAL SUPPORT 
1. Have you disclosed your HIV status? 
Yes 1 
No 2 
 
2. If Yes to whom? 
Sibling 1 
Parent 2 
Grandparent 3 
Aunt or Uncle 4 
Partner 5 
Other 6 
 
3. Did you tell anyone about being on ART? 
Yes 1 
No 2 
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4. Are you worried about friends finding out you are on 
ART? 
Yes 1 
No 2 
 
5. Are you worried about your family finding out you are on 
ART? 
Yes 1 
No 2 
 
6. Are you worried about your partner finding out you are on 
ART? 
Yes 1 
No 2 
 
7. Does anyone in the family support you financially? 
Yes 1 
No 2 
 
8. Which of the following financial support do you receive? 
Social grant 1 
Child grant 2 
Unemployment grant 3 
 
9. Do you participate in support groups of people living with 
HIV/AIDS in the community? 
Yes 1 
No 2 
 
10. Have you ever suffered from any side effects? 
Yes 1 
No 2 
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SECTION C (KNOWLEDGE, ATTITUDES AND BELIEFS ABOUT ART) 
1. Indicate the name of the antiretroviral medications you take. Next, enter the number of 
pills that you have to take each day for each of these medications. (please refer to the 
chart provided) 
 
Name of 
antiretroviral 
medication* 
Number of antiretroviral pills  
 Wake-up, breakfast, 
Morning 
Lunch, 
Afternoon 
Supper, evening, 
bed-time 
Example: 
lamiduvine (3TC, 
Epivir)* 1 
1  1 
1.    
2.    
3.    
*Indicate one of the names of the medication 
2. How many antiretroviral pills have you missed during the last 2 days? 
(If you haven’t missed any, write down the number "0") 
  
Number of antiretroviral pills that you have missed … 
 Wake-up, breakfast, 
Morning 
Lunch, 
Afternoon 
 
Supper, 
evening, 
bed-time 
 
Example 0  0 
Yesterday  
 
  
Day before yesterday    
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3. During the last 7 days, did you … 
                                      YES     NO           YES  NO 
• Go out for a leisure activity? �  � • Go to a restaurant?  �     � 
(movie, show, physical activity, etc.)? 
 
• Go to a bar?    �   �  • Go to a party?         �    � 
• Sleep away from home?  �   �  • Attend a meeting?  �     � 
 
• Visit friend(s) or family �   � • Receive a visit from friend(s)� � 
member(s)?      or family members(s)? 
 
4. During the last 7 days, did one of the situations listed in question Q3 prevent you 
from taking all your antiretroviral pills? 
Yes 1 
No 2 
 
5a. During the last 7 days, how many times, in total, did you miss taking one or more 
of your antiretroviral pills? (If you haven’t missed any, write down the number "0") 
_____ TIMES 
5b. In total, this represents how many antiretroviral pills? _______PILLS 
6. Please identify and tick barriers to your treatment  
Identify barriers to adherence YES NO 
Forgetfulness   
Sleeping away from home   
Daily routine   
Alcohol and drug use   
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Attitudes and beliefs about medication 
1. ART prevent mother to child HIV transmission  
Yes 1 
No 2 
 
2.  HIV can be controlled by ART 
Yes 1 
No 2 
 
3.  ART is effective and prolongs life 
Yes 1 
No 2 
      
4.  HIV can be cured by ART 
Yes 1 
No 2 
 
5.  Taking ART prevents disease progression 
Yes 1 
No 2 
 
6.  Not starting ART when indicated can make you sick 
Yes 1 
No 2 
 
7.  ART improve quality of life 
Yes 1 
No 2 
 
8.  ART medicine can cause side effects 
Yes 1 
No 2 
 
9.  Missing doses of ART leads to disease progression 
Yes 1 
No 2 
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10.  Missing doses of ART increases the risk of 
transmitting HIV 
Yes 1 
No 2 
 
11. Do you believe ART is harmful to your body? Circle 
answer.  
Yes 1 
No 2 
 
12. Do you believe traditional medicine is more effective 
than prescribed medication? 
Yes 1 
No 2 
 
13. Is there anything in your daily routine or work that would 
make it difficult to take medication at specific times?  
Yes 1 
No 2 
 
 
SECTION D HEALTH SERVICES 
  1. It takes a lot of time and time and effort to get your 
HIV medication 
Yes 1 
No 2 
 
  2. If you lost or ran out of your HIV medications it would 
be hard to get more 
Yes 1 
No 2 
 
3. Are you given the chance to state your problem and 
ask questions? 
Yes 1 
No 2 
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4. Are you able to attend the clinic/hospital during the 
service hours? 
Yes 1 
No 2 
 
5. Do you have any problem with travelling to the 
clinic/hospital? 
Yes 1 
No 2 
 
6. Are you treated with respect? 
Yes 1 
No 2 
 
7. Do you feel you trust the health workers? 
Yes 1 
No 2 
 
8. Do you have privacy during consultation and counselling? 
Yes 1 
No 2 
 
9. How long did you spend altogether at the hospital when you last went for review? 
 
10. How long did you have to wait before being attended to? 
 
 
 
 
 
 
 
 
 
 
